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“If our brains were simple enough for us to understand them, 
we’d be so simple that we couldn’t.”
– Ian Stewart
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Summary
The  central  nervous  system  is  the  most  complex  organ  of  the  human  body, 
composed  of  numerous  anatomical  regions  characterized  by  different  cellular 
compositions  and  functions,  and  interconnected  by  complex  communication 
networks. One  of  the  most  tragic  conditions  of  this  organ  is  given  by 
neurodegenerative diseases, that affect millions of people worldwide and are an 
increasing burden for the modern society as the population ages. One of the most  
striking characteristics of most neurodegenerative diseases is that degeneration 
seems to affect specific regions and/or cellular populations of the central nervous 
system.  Although  theories  exist,  the  mechanisms  underlying  this  regional 
vulnerability remain largely unknown. It is likely that transcriptional networks active 
in specific areas of the brain or transcripts expressed in a region-specific way are 
involved in the process. A crucial step to verify this is to establish solid knowledge 
on the transcriptional features characteristic of the aged central nervous system 
and  its  districts.  The  general  aim  of  this  thesis  was  to  gain  insight  into  the 
dynamics  of  transcription  in  the  aged  central  nervous  system and  specifically 
create a high resolution expression profile atlas of distinct brain regions from aged 
donors, to be eventually compared with material derived from patients affected by 
neurodegenerative diseases.  In  Chapter  2,  we present  a pilot  study where we 
profile  transcription  in  5  anatomical  regions  of  the  central  nervous  system.  In 
Chapter 3, as part of the FANTOM5 consortium, we participate in the creation of a 
large expression atlas encompassing a broad array of human and mouse primary 
cells,  cell  lines and tissues. In Chapter 4,  we focus on the 15 central  nervous 
system  regions  included  in  the  FANTOM5  tissue  collection,  representing  an 
expansion of the pilot presented in Chapter 2. In Chapter 5 we use a previously 
published custom microarray non-coding RNA expression dataset generated from 
twelve human tissues to identify brain-specific non-coding RNAs and investigate 
their  characteristics.  Overall,  we  provide  evidence  of  specific  transcriptional 
features that characterize the human central  nervous system and identify large 
arrays of poorly characterized transcripts that are expressed in specific regions 
and might be involved in regional vulnerability in neurodegenerative diseases.
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Resumo
O sistema nervoso central é o órgão mais complexo do corpo humano, composto 
por  várias  regiões  anatómicas  caracterizadas  por  diferentes  composições 
celulares e funções, e interligadas por redes de comunicação complexas. Uma 
das condições mais trágicas do sistema nervoso central é dada pelas doenças 
neurodegenerativas, que afetam milhões de pessoas em todo o mundo e são um 
fardo  crescente  para  a  sociedade  moderna,  por  causa  do  envelhecimento  da 
população.  Uma  das  características  mais  marcantes  da  maioria  das  doenças 
neurodegenerativas é que a degeneração parece atacar regiões e/ou populações 
celulares  específicas  do  sistema  nervoso  central.  Embora  haja  teorias,  os 
mecanismos subjacentes a esta vulnerabilidade local são mal compreendidos. É 
provável que redes de transcrição ou transcritos ativos em áreas específicas do 
cérebro estejam envolvidos nesta vulnerabilidade e perda neuronal localizada. Um 
passo decisivo para testar esta hipótese é estabelecer uma sólida compreensão 
das  características  de  transcrição que  são  típicas  do  sistema nervoso central 
idoso  e  das  suas  partes.  O  objetivo  geral  deste  trabalho  foi  o  de  obter 
conhecimento  detalhado  sobre  a  dinâmica  de  transcrição  no  sistema nervoso 
central  idoso e,  em particular,  criar  um mapa de alta  resolução da expressão 
gênica  em  diferentes  regiões  anatómicas  do  sistema  nervoso  central,  a  ser 
comparado com dados de dadores que sofrem de doenças neurodegenerativas. 
No Capítulo 2, apresentamos um estudo piloto em que analisamos a expressão 
gênica em 5 regiões do sistema nervoso central. No Capítulo 3, como parte do 
consórcio FANTOM5, participamos na criação de um grande atlas da expressão 
gênica  que  inclui  dados  provenientes  de  uma  variedade  exaustiva  de  linhas 
celulares e tecidos humanos e murinos. No Capítulo 4, concentramo-nos nas 15 
regiões  do  sistema  nervoso  central  disponíveis  no  contexto  do  consórcio 
FANTOM5,  que  representam uma expansão  do  estudo  piloto  apresentado  no 
Capítulo  2.  No  Capítulo  5,  usamos  dados  publicados  anteriormente  sobre  a 
expressão  de  RNA não-codificante  em doze  tecidos  humanos  para  identificar 
RNAs  não-codificantes  específicos  do  cérebro  e  investigar  as  suas 
características.  No  geral,  nós  fornecemos  evidência  de  características  de 
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transcrição específicas  que caracterizam o sistema nervoso central  humano e 
identificamos  grandes  matrizes  de  transcritos  mal  caracterizados  que  são 
expressos em regiões específicas e podem estar envolvidos na vulnerabilidade 
regional em doenças neurodegenerativas.
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Abbreviations and symbols used in the thesis
3D = three dimensional
3C = chromosome conformation capture
5C = chromosome conformation capture carbon copy
AD = Alzheimer's Disease
ALS = amyotrophic lateral sclerosis
APP = amyloid-beta precursor protein, gene
bp = base pair
CAGE = cap analysis of gene expression
cDNA = complementary DNA
CGI = CpG Island
ChIA-PET = chromatin interaction analysis with paired-end-tag sequencing
ChIP = chromatin immunoprecipitation
CNS = central nervous system
DNA = deoxyribonucleic acid
ENCODE: encyclopedia of DNA elements
FAIRE = formaldehyde assisted isolation of regulatory elements
FANTOM = functional annotation of mammals
FTD = frontotemporal dementia
FUS = fused in sarcoma, gene
GABA = gamma-Aminobutyric acid
GO = Gene Ontology
GWAS = genome-wide association study
H3K4me1 = monomethylated histone H3 lysine 4, histone modification
H3K27ac = acetylated histone 3 lysine 27, histone modification
H3K9ac = acetylated histone 3 lysine 9, histone modification
HD = Huntington's Disease
HGP = human genome project
HTT = huntingtin, gene
lncRNA = long non-coding RNA
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MAPT = microtubule-associated protein tau, gene
Mb = megabase
ncRNA = non-coding RNA
PD = Parkinson's Disease
RIN = RNA integrity number
RNA = ribonucleic acid
SNCA = alpha-synuclein, gene
SNP = single nucleotide polymorphism
SOD1 = superoxide dismutase 1, gene
TARDBP = TAR DNA Binding Protein, gene, also known as TDP-43
TF = transcription factor
TSS = transcription start site
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Chapter 1 
General introduction
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1.1 Introduction: regional vulnerability in neurodegenerative 
diseases
Neurodegenerative diseases represent a large group of hereditary and sporadic 
neurological  disorders  with  heterogeneous  clinical  and  pathological 
manifestations,  characterized  by  advancing  central  nervous  system  (CNS) 
dysfunction associated to the progressive decay and eventually death of neurons 
(Przedborski  et  al.  2003).  They include diseases such as  Alzheimer's  Disease 
(AD), Frontotemporal Dementia (FTD) and other dementias, Parkinson's Disease 
(PD),  Amyotrophic  Lateral  Sclerosis  (ALS)  and  Huntington's  Disease  (HD). 
Although heterogeneous in their clinical presentation, age of onset, duration and 
progression, certain pathways and biological processes appear to be consistently 
altered. Studies in animal models and patient post-mortem material provide strong 
evidence of increased oxidative stress and impaired mitochondrial  function (Lin 
and Beal 2006;  Johri and Beal 2012), axonal transport defects (Millecamps and 
Julien 2013), defects in the autophagy (Nixon 2013) and mitophagy (Palikaras and 
Tavernarakis 2012; Ashrafi and Schwarz 2013) pathways, endomplasmic reticulum 
stress  and unfolded protein  response (Matus  et  al.  2011;  Hetz  and Mollereau 
2014). It is also well accepted that CNS inflammation has a role in the progression 
of  neurodegenerative  diseases  and  although  it  may  not  typically  represent  an 
initiating factor, there is emerging evidence that sustained inflammatory responses 
involving microglia and astrocytes contribute to disease progression (Glass et al. 
2010; Cunningham 2013). Finally the recent discovery that mutations in the RNA-
binding proteins TARDBP and FUS are causal for up to 8% of the familiar cases of 
ALS (Lagier-Tourenne 2010)  suggests that  improper  RNA processing might  be 
involved in the pathogenesis and progression of at least certain neurodegenerative 
diseases,  such  as  ALS and  FTD.  This  hypothesis  is  further  supported  by  the 
observation  that  a  pathological  feature  of  ALS  and  FTD patients  carrying  the 
c9orf72 repeat expansion mutation show sequestration of RNA binding proteins in 
RNA foci  present  in  the  nucleus or  cytoplasm of  cells  (Lagier-Tourenne et  al. 
2013). 
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Figure 1. Examples of protein aggregates identified in distinct neurodegenerative diseases.  
Amyloid plaques (white arrows) and neurofibrillary tangles (yellow arrows) are typically found in  
post-mortem  brain  material  of  AD  patients  (a).  PD  and  ALS  are  generally  characterized  by  
cytoplasmic aggregates (b. and d.) while in HD intranuclear aggregates are found. Adapted from  
(Soto 2003).
Even  though the  clinical  manifestation  of  all  these  diseases  is  diverse,  at  the 
molecular level they often share the phenomenon of accumulation of abnormally 
folded  proteins  in  the  form  of  small  oligomers,  aggregates  or  large-protein 
inclusions.  The accumulation  of  distinct  protein-based macroscopic  deposits  is 
therefore  a  hallmark  of  neurodegenerative  diseases  and  the  composition  and 
distribution of the deposits is a defining property of each of them (Figure 1). For 
example  AD is  characterized by extracellular  amyloid  plaques and intracellular 
neurofibrillary  tangles (Gamblin et  al.  2003);  PD by characteristic  intraneuronal 
cytoplasmic  inclusions –  termed Lewy Bodies  –  composed of  several  proteins 
(Dauer  and  Przedborski  2002);  distinct  subtypes  of  FTD by  tau-  or  ubiquitin- 
positive deposits in neurons and glia (Bigio 2013); HD by intracellular aggregates 
called inclusion bodies (IBs). Some of the mutations associated with familial cases 
of these diseases affect the major protein components of the deposits: e.g. the 
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identification of mutations in the alpha-synuclein gene (SNCA) in familiar forms of 
PD (Polymeropoulos  et  al.  1997)  eventually  led  to  the  discovery  of  SNCA as 
principal  component  of  Lewy  bodies.  Analogously  the  beta-amyloid  precursor 
protein (APP), first causal gene identified for AD (Goate et al. 1991), is a major 
component  of  amyloid plaques characteristic of  AD (Glenner and Wong 1984). 
Additionally FTD familial cases associated to MAPT mutations show neuronal and 
glial deposits staining positive for MAPT (Hutton et al. 1998) while in familial forms 
of ALS associated with  FUS mutations abnormal cytoplasmic glial and neuronal 
inclusions staining positive for FUS were observed (Lagier-Tourenne et al. 2010). 
Finally the IBs that characterize HD stain positive for mutant huntingtin (HTT) and 
ubiquitin (Arrasate and Finkbeiner 2012). In light of these and similar observations, 
neurodegenerative  diseases are  currently  viewed as  cerebral  proteopathies,  in 
which the accumulation of particular proteins is a key causative factor (Haass and 
Selkoe 2007).  Another common feature of most neurodegenerative diseases is 
that deposit formation, pathology and eventually neuronal loss  is restricted to a 
limited number of brain regions or subsets of neurons (Saxena and Caroni 2011; 
Jackson 2014) (Figure 2). In AD initial symptoms are related to prominent memory 
impairment and this correlates to focused neurodegeneration in hippocampus and 
parahippocampal gyrus (Hyman 1984). PD predominantly manifests clinically as a 
movement  disorder  and  is  associated  to  the  initial  degeneration  and  loss  of 
dopaminergic  neurons in  the substantia nigra (Sulzer and Surmeier 2013).  HD 
manifests  as  well  as  a  movement  disorder,  however  neuronal  loss  is  initially 
restricted to the GABAergic neurons of striatum (Ross and Tabrizi 2011). ALS is 
characterized by  the  selective  and progressive  loss  of  upper  and lower  motor 
neurons of the brainstem, spinal cord and cerebral cortex (Robberecht and Philips 
2013).  The  mechanisms  underlying  this  selective  vulnerability  remain  largely 
unknown: one immediate explanation would be that the genes specifically involved 
in  protein aggregation in distinct  neurodegenerative diseases are expressed at 
higher levels in the areas that are affected the most. However, this hypothesis is 
easily challenged by the observation that e.g.  APP,  HTT,  SNCA and  FUS have 
essentially  similar  levels  of  expression  in  both  affected  and  unaffected  areas 
(Figure 3). 
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Figure 2. Schematic representation of regional vulnerability in neurodegenerative diseases.  
In AD neurodegeneration initially affects the hippocampus and parahippocampal gyrus. In PD initial  
degeneration and neuronal loss is localized to the substantia nigra. In HD neuronal loss is initially  
restricted  to  the  GABAergic  neurons  of  striatum.  ALS  is  characterized  by  the  selective  and  
progressive loss of  upper and lower motor neurons of the brainstem, spinal  cord and cerebral  
cortex. Adapted from (Mattson and Magnus 2006).
An  intriguing alternative  explanation  is  that other  genes  directly  or  indirectly 
interacting with the ones that are mutated are differently expressed in the most  
vulnerable regions and contribute to a localized alteration of either expression or 
physical/functional properties of the mutated genes. This suggests that to achieve 
a broader understanding of regional vulnerability in neurodegenerative diseases, a 
crucial  step is to move from single genes to genome-wide expression profiling 
approaches, that can survey simultaneously all genes expressed in one sample 
and find differences in expression in an unbiased way, shedding light into region 
specific regulation of transcription by identifying networks of co-regulated genes.
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Figure  3.  Expression  patterns  across  distinct  regions  of  the  human  CNS  and  across  
different ages for four genes linked to familial forms of neurodegenerative diseases.  For 
each panel, the x-axis represents age (days) and the y-axis represents normalized expression (as  
Log2 of signal intensity). Each dot represents a sample, each color represents a region of the CNS  
and solid lines summarize the expression profiles for the genes APP, HTT, SNCA and FUS. The  
expression  of  these  genes  is  essentially  similar  across  regions  affected  and  non-affected  by  
neurodegeneration  in  the  corresponding  disease.  Data  from  Human  Brain  Transcriptome  
(http://hbatlas.org/).
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1.2 The Human Genome Project: putting the basis for genome-
wide expression profiling
One of the major scientific achievements of the last century, fundamental to put the 
basis for genome-wide expression profiling studies, was the sequencing of the full  
human  genome.  Under  the  name  of  Human  Genome  Project  (HGP)  several 
groups  from several  countries  in  the  world  joined  a  collaborative  public  effort 
(conceived  in  1984  and  officially  started  in  1990)  with  the  primary  aim  of  
determining the nucleotide sequence of the entire human nuclear genome and 
discovering all human genes. The public effort was paralleled in 1998 by a private 
company  (Celera  Genomics  of  Maryland,  USA),  aiming  at  reaching  the  same 
result with a faster and more cost-effective approach (Brown 2002). Both projects 
concluded successfully with the release of human genome working drafts in 2001 
(Lander et al. 2001; Venter et al. 2001), completed in the definitive version in 2004 
(International  Human  Genome  Sequencing  Consortium  2004).  The 
accomplishment  of  the  HGP  started  the  field  of  genomics  and  dramatically 
contributed to shaping several fields of biology into the form they have now, from 
basic biology, to comparative and medical genomics. In basic biology, it reshaped 
our view of the genome physiology, including a precise definition of the number, 
distribution and structure of protein-coding genes, the discovery of novel classes 
of non-coding RNAs (ncRNAs) and the completely unexpected pervasiveness of 
transposon-derived  sequences,  accounting  for  up  to  45%  of  the  genomic 
sequence (Lander  et  al.  2001).  Along with  the  closely  following sequencing of 
genomes  of  other  species  (such  as  mouse  (Mouse  Genome  Sequencing 
Consortium  2002),  rat  (Gibbs  et  al.  2004)  and  chimpanzee  (Chimpanzee 
Sequencing and Analysis Consortium 2005)) it boosted the field of comparative 
genomics, which brought e.g. to the surprising discovery that while the exomes of 
human  and  mouse  are  extremely  similar,  a  substantial  excess  of  conserved 
sequence,  likely  functional,  does  not  code  for  proteins  (Mouse  Genome 
Sequencing  Consortium  2002).  The  accomplishment  of  the  HGP also  greatly 
pushed forward disease research: when the project was launched, less than 100 
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mendelian disease genes had been identified. With the genetic and physical maps 
created in the first stages of the HGP the list quickly began to grow and a decade 
after  more  than  2,850  Mendelian  disease  genes  had  been  identified  (Lander 
2011). Similar advances were seen in uncovering the basis of common diseases: 
as of 2000, only about a dozen genetic variants (outside the HLA locus) had been 
reproducibly associated with common disorders; a decade later, more than 1,100 
loci affecting more than 165 diseases and traits had been associated with common 
traits and diseases (Lander 2011; Naidoo et al. 2011). Overall the greatest impact 
of  genomics  has  been  the  ability  to  investigate  biological  phenomena  in  a 
comprehensive,  unbiased,  hypothesis-free  manner,  also  thanks to  the  creation 
since of several publicly accessible databases collecting information about genes 
(e.g. Ensembl (Flicek et al. 2014) and GENCODE (Harrow et al. 2012)), SNPs and 
human  variation  (e.g.  dbSNP  (Sherry  2001),  HapMap  (International  HapMap 
Consortium  2003),  1000  Genomes  Project  database  (1000  Genomes  Project 
Consortium  2012))  and  many  others.  As  a  collateral  consequence,  the  HGP 
challenge  directly  influenced  and  accelerated  the  evolution  of  sequencing 
technology, which went paired with the decrease in sequencing costs that we are 
still  observing.  The  advent  of  high-throughput  sequencing  revolutionized  and 
became  an  integral  part  of  many  areas  of  biological  research.  In  particular  it 
started a new age for the study of transcriptomes and transcriptional regulation: 
the two major consortia working in the field and their results are outlined in the  
next section.
1.3 Understanding transcriptional regulation: ENCODE and 
FANTOM
Although all cells in the human body share essentially the same genetic code, they 
vary hugely in their structures and functions. Sequencing the whole genome alone 
does not explain how this large variety is achieved starting from the same material  
– the DNA present in the nucleus of each cell of an individual. In the last decade 
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considerable efforts were made to investigate this. In particular I will outline here 
the  main  achievements  of  two  large  international  consortia  dedicated  to  the 
investigation of transcription and its regulation: FANTOM and ENCODE. Besides 
rewriting considerable chapters of schoolbook biology and giving immense insight 
into the biology of transcription, starting from redesigning the concept of “gene”, 
they  produced  in  the  years  wealths  of  data  freely  accessible  to  the  scientific 
community and probably daily used in many laboratories in the world, to generate 
and test hypotheses and design experiments.
1.3.1 ENCODE: ENCyclopedia Of DNA Elements
The ENCODE project was launched in September 2003 as follow-up of the HGP, 
with  the  aim of  identifying  all  functional  elements  in  the  human genome.  The 
ENCODE project developed in two distinct parts: a pilot (2003-2007), focusing on 
about  1% of  the sequenced genome to test  and compare existing methods to 
rigorously analyze a given region of the genome (ENCODE Project Consortium, 
Birney et al.  2007), and a first production phase (2007-2012), that scaled up the 
methods  tested  to  the  full  genome,  also  thanks  to  the  introduction  in  the 
meanwhile  of  next  generation  sequencing  (ENCODE  Project  Consortium, 
Bernstein  BE et  al.  2012).  Overall  the ENCODE project  efforts resulted in  the 
generation  of  thousands of  genome-scale  data  sets  encompassing  transcripts, 
sites  of  transcription  factor  (TF)  binding  for  large  arrays  of  TFs,  DNase  I 
hypersensitive  sites,  histone  modifications  and  other  functional  features 
(Stamatoyannopoulos 2012) (the major assays at the basis of ENCODE Project 
are  summarized  in Box  1).  By  studying  the  distribution  of  these  biochemical 
signatures across distinct cell types, the ENCODE projects gave immense insight 
into the mechanisms involved in cell-specific regulation of transcription (Arvey et 
al. 2012; Djebali et al. 2012; Thurman et al. 2012), the combinatorial patterns of 
TFs needed to achieve this precise regulation  (Gerstein et al. 2012; Wang et al. 
2012), and their likely genic targets (Sanyal et al.  2012; Thurman et al.  2012). 
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Starting  from the  basics,  results  from ENCODE and  FANTOM (see  also  next 
section) redefined the unit of transcription. Although the "gene" was conventionally 
viewed as the fundamental unit of genomic organization, on the basis of ENCODE 
data it is now evident that the fundamental unit is rather the "transcript" (Washietl 
et al.  2007; Djebali  et al. 2012). Genes represent a higher-order organizational 
level, in which individual transcripts are used in different cellular states, guided by 
differential utilization of regulatory DNA. The majority of regulatory DNA regions 
are highly  cell-type and cell-state  specific  (ENCODE Project  Consortium 2012; 
Thurman et al. 2012): considering a single cell type up to 1-2% of the DNA has 
regulatory function; however the frequency of regulatory DNA along the genome 
grows as the number of cell types and states assayed increases: it is expected 
that  40%  and  possibly  more  of  the  genome  sequence  encodes  regulatory 
information (ENCODE Project  Consortium 2012).  The large variety  of  datasets 
produced  by  ENCODE  led  to  the  establishment  that  one  of  the  fundamental 
aspects  of  transcriptional  regulation  lies  in  the  dynamic  interplay  between 
chromatin  and  transcriptional  machinery  (Stamatoyannopoulos  2012):  e.g. 
transcription  originating  from  enhancer  elements  is  predominantly  detected  at 
distal DNase I hypersensitive sites flanked by H3K4me1, H3K27ac, and H3K9ac 
histone  modifications,  as  extensively  documented  in  (Djebali  et  al.  2012). 
Additionally, the use of assays able to determine long-range chromatin interactions 
such as Chromosome Conformation Capture Carbon Copy (5C) (Dostie 2006) or 
Chromatin  Interaction  Analysis  with  Paired-End-Tag  sequencing  (ChIA-PET) 
(Fullwood  et  al.  2009)  showed  that  specific  physical  interactions  and  3D 
connectivity  of  genes  with  one  another  and  with  their  respective  controlling 
elements appear to be general properties of long-range regulatory control (Li et al. 
2012; Sanyal et al. 2012). Finally, it is now apparent that a significant proportion of  
strongly  disease-  or  trait-associated  variants  emerged  from  genome-wide 
association studies (GWAS) localize within regulatory DNA marked by DNase I 
hypersensitive  sites  and  selected  TFs  (ENCODE  Project  Consortium  2012; 
Maurano et al. 2012; Schaub et al. 2012).
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Box 1: Major techniques used by the ENCODE Project.
Graphical  summary  of  the  major  techniques  used  by  the  ENCODE  Project.  Adapted  from  
(ENCODE Project Consortium 2012).
RNA-seq:  RNA isolation,  typically  performed in  the ENCODE Project  with  multiple  purification 
protocols  to  separate  distinct  sub-cellular  fractions  and  transcript  types,  followed  by  high-
throughput sequencing.
ChIP-seq:  Chromatin  immunoprecipitation  (ChIP)  followed  by  high-throughput  sequencing. 
Specific regions of cross-linked chromatin, i.e. genomic DNA in complex with its bound proteins, 
are selected by using an antibody to a specific epitope. The enriched sample is then sequenced to  
determine the regions in the genome most often bound by the protein to which the antibody was 
directed.  Most  commonly  used  are  antibodies  to  any  chromatin-associated  epitope,  including 
transcription factors,  chromatin binding proteins and specific chemical  modifications on histone 
proteins.
DNase-seq: Adaptation of DNase footprinting assay to high-throughput sequencing. The DNase I 
enzyme preferentially cuts chromatin preparations at sites nearby bound proteins. The resulting cut 
points are sequenced to determine those genomic regions that are ‘hypersensitive’ to DNase I, 
corresponding to accessible DNA (also termed “open chromatin”).
FAIRE-seq:  Formaldehyde  assisted  isolation  of  regulatory  elements  (FAIRE).  FAIRE  isolates 
nucleosome-depleted  genomic  regions  by  exploiting  the  difference  in  crosslinking  efficiency 
between nucleosomes (high) and sequence-specific regulatory factors (low).  FAIRE consists of 
cross-linking, phenol extraction, and sequencing the DNA fragments in the aqueous phase.
3C  and  5C:  Chromosome  Conformation  Capture  (3C)  uses  formaldehyde  cross-linking  to 
covalently trap interacting chromatin segments throughout the genome. Interacting elements are 
then restriction-enzyme-digested and intramolecularly ligated and the frequency with which two 
restriction  fragments become ligated is  a  measure  of  the  frequency  of  their  interaction  in  the 
nucleus. 3C uses PCR to detect individual chromatin interactions, which is not applicable for large-
scale identification of  chromatin interactions.  To overcome this problem, 3C-Carbon Copy (5C) 
uses highly multiplexed ligation-mediated amplification to first copy and then amplify parts of the 
3C library, followed by detection on microarrays or by quantitative DNA sequencing.
ChIA-PET: Chromatin Interaction Analysis with Paired-End-Tag sequencing. Combines chromatin 
immunoprecipitation  and  chromosome conformation  capture  to  identify  long-range  interactions 
mediated by a protein of interest genome-wide, using paired-end tag libraries.
1.3.2 FANTOM: Functional ANnoTation Of Mammals
To some extent  parallel  to  the  ENCODE project,  FANTOM is  an  international 
research consortium established in 2000 to assign functional annotations to the 
full-length  cDNAs  that  were  collected  during  the  Mouse  Encyclopedia  Project, 
established in 1995 at RIKEN (Japan), with the aim of sequencing all expressed 
RNAs. FANTOM has gradually developed and expanded over time to encompass 
the field of transcriptome analysis. The object of the project progressed from an 
understanding of the “elements” – the transcripts – to an understanding of the 
“system” – the transcriptional regulatory networks – active in individual life forms 
and  specific  to  each  cell.  FANTOM1  and  FANTOM2  projects  focused  on  the 
determination  of  the sequences and functional  annotation  of  large sets  of  full-
length  mouse  cDNAs.  The  consortium cloned and  annotated over  80,000 full-
length  cDNAs  from a  wide  range  of  mouse  tissues  and  integrated  them with 
existing  annotations,  allowing  for  the  identification  of  ca.  16,000  novel 
transcriptional units. This fundamentally contributed to the estimate of the number 
of genes that are part of the mouse genome, supported the innovative concept 
that most genes are associated to a large variety of transcripts and that alternative 
TSS usage and splicing are widespread phenomena (Kawai et al. 2001; Okazaki 
et al. 2002). Additionally the consortium reported the transcription of about 15,000 
ncRNAs,  of which only about 100 had been previously identified, suggesting for 
the first time the transcription of RNAs that do not code for proteins is a pervasive 
feature  in  mammalian  genomes  (Okazaki  et  al.  2002). In  FANTOM3,  besides 
working  with  full-length  cDNAs,  the  FANTOM  consortium  utilized  a  new 
technology, Cap Analysis of Gene Expression (CAGE (Kodzius R et al. 2006); see 
also Box 2), to reveal that more than 63% of the mouse and human genomes is 
transcribed  as  RNA,  instead  of  the  ca.  1.5% fraction  of  protein-coding  exons 
known  at  that  time  (Carninci  et  al.  2005).  Additionally  the  expression  of  over 
23,000 ncRNAs was confirmed and it was shown for the first time that over 73% of 
the transcriptional units show sense-antisense transcription (Carninci et al. 2005; 
Katayama et al. 2005). Work from the consortium brought to the discovery that 
mammalian promoters can be separated into two classes: "sharp" and "broad". 
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The first class represents classical promoters for which transcription initiates at a 
well defined position restricted to few bp; these are enriched for conserved TATA-
box motifs, are usually tissue-specific and surprisingly represent a minority of the 
transcription start sites (TSSs). The second class, much larger, is characterized by 
TSSs spread across several bp; these are typically located in CpG islands and 
correspond  to  genes  of  broader  use.  Different  tissues  and  families  of  genes 
differentially use distinct types of promoters and the usage of alternative start sites 
is common (Carninci et al. 2006). In FANTOM4 the focus moved to understanding 
how these components work together in the context of a biological network. Using 
CAGE adapted to high-throughput sequencing technology, the dynamics of TSS 
usage  during  a  time  course  of  monocytic  differentiation  in  the  acute  myeloid 
leukemia cell line THP-1 was monitored. This allowed for the precise identification 
of active promoters and their expression levels. Computational methods were then 
used  to  build  a  network  model  of  gene  expression  that  identified  the  key 
transcriptional  regulators  in  the  differentiation  process,  their  time-dependent 
activities  and  their  target  genes,  which  were  confirmed  by  systematic  siRNA 
knock-down experiments. This study was pioneering in the discovery that cell-state 
and  cell-fate  are  determined  by  complex  networks  involving  both  positive  and 
negative  regulatory  interactions  among  substantial  numbers  of  TFs  (FANTOM 
consortium et al. 2009). The latest FANTOM project, presented in Chapter 3 of this 
thesis, ambitiously aimed at expanding the horizon and create a map of the vast 
majority  of  human  promoters  and  identify  the  regulatory  networks  that  define 
virtually every single cell type in a human being.
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Box 2: CAGE – Cap Analysis of Gene Expression
Graphical representation of the CAGE protocol adapted for use with HeliScope single-molecule  
sequencer. Adapted from (Kanamori-Katayama et al. 2011).
Cap  Analysis  of  Gene  Expression  (CAGE)  is  a  technology  developed  at  RIKEN,  Japan,  that 
produces a quantitative snapshot of the 5' ends of capped mRNAs in a biological sample. The 
ultimate output of a CAGE experiment is a set of short nucleotide sequences, often called tags, 
with  their  observed  counts.  The  original  CAGE  library  preparation  protocol  involved  cDNA 
synthesis, cap-trapping of 5′ complete cDNA/capped RNA hybrids, second-strand synthesis, linker 
ligation, full-length cDNA cloning in bacteria, digestion of 5′ tags, and concatenation and subcloning 
of concatemers prior to capillary sequencing (Shiraki et al. 2003). An adaptation of the protocol for 
the 454 sequencer was later developed and used as leading technology for the accomplishment of 
the FANTOM4 project (FANTOM Consortium et al. 2009). Both the original and the 454-adapted 
protocols required several handling steps and PCR cycles, potentially introducing artifacts and PCR 
biases.  The  simplified  HeliScope  CAGE  protocol,  schematically  represented  above,  aimed  at 
reducing  handling  steps  and  avoiding  PCR amplifications,  to  overall  improve  the  quantitative 
features of  the technique.  Briefly,  HeliScope CAGE library  preparation can  be summarized  as 
follows: (a) first-strand cDNA is generated from total RNA using an excess of random primer (b) the 
5′ end complete first-strand cDNAs are captured through the cap structure (c) first-strand cDNA is 
poly(A)-tailed and blocked, then loaded directly onto the HeliScope flow cell  for sequencing. An 
optimized protocol for CAGE library production directly applicable to Illumina sequencers was later 
published and is the procedure currently used in our lab (Takahashi et al. 2012). 
1.4 Outlook and thesis aims
Work from large consortia such as ENCODE and FANTOM put the basis for the 
comprehensive understanding of the biology of transcription. At the same time one 
of  the  fundamental  observations  that  emerges  from  these  studies  is  that 
transcription  is  tightly  regulated  in  a  cell-  and  tissue-dependent  manner. 
Considering  that  neurodegenerative  diseases  show a  high  degree  of  regional 
vulnerability and neuronal loss, transcriptional features, perturbations or transcripts 
that are specific for the regions involved may have a role in their pathogenesis. To 
gain a more precise understanding of region-specific regulation of transcription in 
brain  and  consequently  region-specific  vulnerability  in  neurodegenerative 
diseases,  genome  wide  transcription  profiling  studies  specifically  focusing  on 
appropriate sets of control and disease brain samples are needed. As for 2009, 
when this PhD project started, the only large expression profiling work performed 
on a comprehensive selection of different regions of the human post-mortem CNS 
and non-CNS tissues was (Roth et al. 2006). The main conclusions of this study 
were that CNS regions are significantly different from non-CNS tissues and similar 
between  them,  while  the  20  CNS  regions  profiled  could  be  segregated  into 
discrete groups with underlying similarities in anatomical structure and functional 
activity.  Besides this  study,  a  repertoire  of  other  expression  profiling  works  on 
arrays  of  tissues that  included brain  samples  suggested over  the  years  some 
general features of brain transcription. In particular it  was suggested that brain 
tissue is characterized by the highest number of genes expressed (Ramsköld et al. 
2009)  and  by  the  highest  transcriptional  complexity  (Jongeneel  et  al.  2005; 
Ramsköld  et  al.  2009),  by  over-representation  of  expressed  simple  and  low-
complexity  repeats  with respect  to  other  tissues  (Faulkner  et  al.  2009)  and 
transcripts originating in CG rich regions (Roider et al. 2009). Additionally, work in 
mouse suggested that brain tissues express a large array of ncRNAs (Mercer et 
al. 2008).
With this perspective in mind, the work presented in this thesis is the first step of 
an ongoing effort to precisely characterize brain-specific and particularly region-
30
specific transcription of coding and non-coding genes in the human aged brain. 
This is achieved by creating a high resolution expression profiling atlas of different  
areas  of  the  human  aged  brain,  with  the  long  term  aim  of  investigating  the 
networks that are transcriptionally altered in disease and functionally characterize 
the transcriptional networks involved. 
The specific aims of this thesis can be summarized as:
• gain general insight into the dynamics of transcription in the CNS
• specifically create a high resolution expression profile atlas of distinct brain 
regions from aged donors
• extend the atlas to matched disease samples to identify and functionally 
validate networks of co-expressed transcripts perturbed in disease
1.5 Thesis outline
In  Chapter  2,  we used CAGE to  profile  transcription  in  5  regions of  the  CNS 
(caudate, putamen, frontal and temporal cortices, and hippocampus) derived from 
post-mortem material  of  human aged  donors  and  additionally  investigated  the 
methylation  landscape  in  the  same  regions.  We  first  characterized  the 
transcriptome  of  aged  human  brain  and  evaluated  the  extent  of  alternative 
promoter usage. Then, we quantified differences in gene expression and promoter 
usage  across  the  5  brain  regions.  Finally,  we  analyzed  the  extent  to  which 
methylation influenced the observed expression profiles.
In  Chapter 3, as part of the FANTOM5 consortium, we used CAGE adapted to 
single molecule sequencing to map TSSs and their usage in human and mouse 
primary cells, cell lines and tissues to produce a comprehensive overview of gene 
expression across the human body. 
In  Chapter  4,  we  focused  in  particular  on  the  CNS  samples  included  in  the 
FANTOM5 tissue collection, representing 15 regions of the human CNS, derived 
from  post-mortem  material  from  aged  donors.  First  we  compared  the  CNS 
expression signature and transcriptional complexity to the other tissues present in 
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the  collection  and  characterized  the  transcriptional  context  of  transcripts  up-
regulated  in  brain.  Additionally  we  investigated  differential  expression  across 
distinct CNS regions.
In  Chapter  5 we  used  a  previously  published  custom  microarray  ncRNA 
expression dataset generated from twelve human tissues to identify tissue-specific 
ncRNAs. We investigated the relative abundance of ncRNAs across tissues and 
correlated brain-specific ncRNAs expression to neighboring protein-coding genes. 
Additionally  we  investigated  repeat  representation  at  the  origin  and  in  the 
transcript body of brain-specific ncRNAs.
In Chapter 6 I will summarize the results presented in this thesis and discuss the 
major discoveries and limitations in the context of the advances in CNS-centered 
expression profiling studies since 2009. Additionally I'll present future applications 
and approaches that, making use of the work presented in this thesis, can provide 
further insight into brain-specific and region-specific transcripional regulation and 
ultimately  into  the  regional  vulnerability  that  characterizes  many 
neurodegenerative diseases.
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Regional differences in 
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promoter usage in aged 
human brains
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Abstract
The human CNS is  an  extremely complex  organ that  governs our  abilities  for 
cognition,  reasoning  and  emotions  and  is  the  control  center  for  the  body.  Its 
morphology and functionality during development have been well studied, but the 
molecular mechanisms contributing to its function and maintenance later in life 
remain poorly understood. Complexity at the transcriptional level is likely to play a 
major  role  in  defining  its  morphological  and  functional  characteristics.  To 
investigate  this  we used single  molecule  Cap Analysis  of  Gene Expression  to 
create a high-resolution atlas of transcription start sites for 15 anatomical regions 
of the human central nervous system, using post mortem samples derived from 
three aged adult donors. Sequencing on average 5 million reads per sample, we 
identified 95912 CAGE-defined tag clusters (TCs), supporting the expression of 
19018 genes. Using the largest tissue collection produced to date with a uniform 
platform we show that the CNS has a unique expression signature, not limited to 
protein coding genes but extending to lncRNAs and novel transcripts. Additionally, 
it is distinguished by a significantly higher transcriptional complexity. We show that 
transcripts up-regulated in brain arise in a specific transcriptional context, being 
more often transcribed from CG rich regions, simple and low complexity repeats.  
We identify a set of 183 transcription factors and 206 lncRNAs up-regulated in 
brain which co-expression patterns identify super-groups of regions with related 
function/developmental  derivation. 9758 TCs are differentially expressed across 
regions,  representing four  major  co-expression groups,  each of  which includes 
genes that are known to be relevant for the function of the associated regions. E.g. 
TBR1 and  ARNT2  transcription  factors  and  cortex  markers  FXYD6,  CCK and 
CBLN2  belong  to  the  co-expression  group  associated  with  cortex  and  limbic 
system. In addition we find in this group 37 lncRNAs of unknown function and 147 
intergenic  TCs,  over  74% of  which  overlap frontal-derived H3K4me3 ChIP-seq 
data, strongly supporting that they correspond to genuine novel transcripts. Due to 
its high-resolution and the large variety of CNS regions represented, this study 
provides an invaluable resource for understanding region-specific transcriptional 
regulation  and  provide  testable  hypotheses  that  can  be  followed  up  in  the 
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laboratory.
Introduction
The  human  brain  is  an  exceptionally  sophisticated  organ  divided  into  distinct 
anatomical districts that are characterized by specific cellular compositions and 
functions and are interconnected by intricate communication networks. Complexity 
at the transcriptional level is likely to play a major role in the establishment and 
maintenance of the morphological and functional complexity of the brain and its 
multifaceted parts. Studies to date, investigating genome wide expression profiles 
of the human central nervous system across different regions and developmental 
stages (Roth et al. 2006; Kang et al. 2011; Colantuoni et al. 2011; Hawrylycz et al. 
2012)  have  provided  invaluable  insight  into  the  transcriptional  dynamics  and 
regulation in different areas of the human brain. However, these studies mostly 
relied  on  array-based  technologies  that  are  biased  in  their  probe  design  and 
limited by their inability to detect novel transcripts and transcript isoforms, or to 
distinguish between closely related paralogous sequences. In addition they often 
cannot quantify absolute expression (Fu et al. 2009). Next generation sequencing 
(NGS) is rapidly replacing microarrays as the technique of choice for transcription 
profiling studies in an effort to overcome these limitations. Cap analysis of gene 
expression (CAGE) is a transcriptome exploration technology that captures the 5’ 
end  of  capped  RNA transcripts  (Kodzius  et  al.  2006;  Takahashi  et  al.  2012) 
allowing for  the high resolution profiling of  transcription start  sites  (TSSs)  in  a 
quantitative  and  annotation-independent  manner.  CAGE has  been  successfully 
employed  to  profile  transcription  in  several  organisms  and  clonal  cell  lines  in 
varying experimental conditions (FANTOM consortium 2009; Hoskins et al. 2011; 
Plessy et al. 2012; ENCODE Project Consortium 2012) giving novel insights into 
mammalian  transcriptional  regulation  (Lenhard  et  al.  2012)  and  has  been  the 
technology of choice of the FANTOM (Functional Annotation of the Mammalian 
Genome) consortium (FANTOM Consortium 2009). The FANTOM5 project uses 
CAGE, adapted to the single-molecule sequencer Heliscope (Kanamori-Katayama 
62
et al.  2011) to avoid additional PCR steps and improve its quantitativeness, to 
profile  over  900 human tissues,  primary  cells  and cell  lines,  aiming to  build  a 
complete promoter map to uncover the transcriptional regulatory networks defining 
every human primary cell  type (Forrest et  al.  2014).  As part  of  FANTOM5, we 
profiled transcription for 15 regions of the human central nervous system (CNS, 
Table 1, Supplementary Figure 1), using post mortem tissue from three aged adult 
donors. The regions belong to distinct anatomical and functional domains and are 
involved in a wide range of neurological phenotypes, including major diseases. 
Our data extend and complement microarray-based brain gene expression studies 
(Roth et al. 2006; Kang et al. 2011; Colantuoni et al. 2011; Hawrylycz et al. 2012),  
the recently published ENCODE data (primarily based upon a limited set of clonal 
cell lines (ENCODE Consortium 2012)) and our previous work (based on CAGE 
profiling of a set of five brain regions (Pardo et al. 2013)).
This study provides an important resource for in depth brain specific functional 
annotation. Using the largest collection produced to date with a uniform platform 
we show that brain has a distinctive expression signature with respect to other 
tissues, not limited to protein coding genes but extending to lncRNAs and novel  
transcripts. Additionally, it is distinguished by a higher transcriptional complexity, to 
which non-coding transcripts importantly contribute. We show that transcripts up-
regulated in  brain  are characterized by a specific transcriptional  context,  being 
often  derived  from CG rich  regions  and  specific  classes  of  repeats.  We  also 
identify a set of transcription factors and lncRNAs up-regulated in brain, that might 
have an important role in brain-specific transcriptional regulation. We assess the 
extent of regionally biased transcription across distinct regions of the adult brain,  
highlighting a set of locally expressed lncRNAs and transcription factors. This work 
is part of the FANTOM5 project. Data downloads, genomic tools and co-published 
manuscripts are summarized at http://fantom.gsc.riken.jp/5/.
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Results
The complex transcriptome of the human brain
We identified 95,912 tag clusters (TCs) expressed in the human CNS, 95.0% of 
which could be associated to 19,018 GENCODE genes. 78.9% and 16.9% of the 
annotated TCs mapped to protein-coding and non-coding transcripts respectively. 
The most represented non-coding biotypes were processed transcripts (47.0%), 
retained introns (23.9%) and long non-coding RNAs (lncRNAs) (8.7%) (Table 2). 
We  also  identified  4,779  (5.0%)  TCs  mapping  to  previously  un-annotated, 
intergenic  regions,  representing  bona  fide  novel  transcripts.  Using  the  publicly 
available  ChIP-seq  dataset  published  in  (Shulha  et  al.  2013),  which  reports 
genome wide maps for the histone H3K4me3 (associated with promoters that are 
active  or  poised  to  be  activated  (Barski  et  al.  2007))  in  nuclei  collected  from 
prefrontal cortex, we found that 34.5% of these intergenic TCs overlap H3K4me3 
signature, supporting the hypothesis that they represent TSSs of novel transcripts.
Using the FANTOM5 tissue collection and the advantage of having a broad set of 
samples  profiled  with  the  same  technology  (35  CNS  tissues  and  91 
heterogeneous non-CNS tissues, listed in Supplementary Table 1), we were able 
to investigate overall expression differences between CNS and other tissues. We 
produced multidimensional scaling (MDS) plots of CAGE expression profiles for 
four subsets of the data, representing coding genes, transcription factors, lncRNAs 
and intergenic TCs. As shown in Figure 1 (panels a. to d.) for all the four groups 
the CNS tissues clustered together  and were clearly separated from the other 
tissues,  showing that  the CNS expresses a specific range of coding genes (in 
particular  transcription  factors)  and  lncRNAs,  and  is  also  distinguished  by  the 
expression patterns of putative novel transcripts. Additionally, analogous clustering 
based  on  transcribed  enhancers  (Andersson  et  al.  2014,  Figure  3)  similarly 
showed that CNS samples clearly separate from other FANTOM5 human tissues. 
These results show that the CNS expression signature is distinctive with respect to 
other tissues, not only on the level of coding genes but also on lncRNAs, novel 
transcripts  and  transcriptional  regulators,  such  as  transcription  factors  and 
enhancers. This is particularly interesting in light of the fact that although the non-
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CNS tissues are extremely heterogeneous, they form an homogeneous cluster 
with respect to CNS samples.
One hypothesis to explain this remarkable separation is that brain tissues express 
a  broader  range  of  transcripts,  therefore  inducing  the  expression  patterns 
observed.  To  assess  this  we  examined  the  cumulative  distribution  of  tags 
accounted for by the 10,000 most highly expressed TCs in each tissue library: as 
shown in Figure 1e in general the curves that represent CNS samples grow slower 
than  the  ones  representing  other  tissues,  suggesting  that  brain  has  a  more 
complex and diversified transcriptome. To quantify this, we calculated the number 
of  TCs required  to  cover  at  least  50% of  the  tags sequenced in  each of  the 
libraries,  similarly  to  what  was  described  in  (Jongeneel  et  al.  2005).  These 
numbers, referred to as N50, can be considered as a measure of transcriptional 
complexity, since tissues with simple transcriptional programs are characterized by 
a low N50 value (e.g. in the library prepared from salivary gland the two most 
highly  expressed  TCs,  mapping  to  the  genes  Submaxillary  Gland  Androgen 
Regulated Protein 3B and Statherin, accounted for almost 60% of the total tags 
sequenced in that library, therefore N50 for salivary gland was 1). Comparing N50 
values for the CNS samples against the other tissues, we observed a significant 
difference (p−value = 1.213e-09, Wilcoxon rank sum test, Figure 1f) showing that 
in  general  CNS  samples  give  rise  to  more  complex  libraries.  Repeating  this 
analysis  based  only  on  TCs  mapping  to  non-coding  loci  we  still  obtained  a 
significant difference between CNS and other tissues (Supplementary Figure 2), 
showing that the non-coding fraction contributes significantly to the complexity of 
brain transcriptome.
Trancripts up-regulated in brain
To identify TCs with higher expression in the CNS with respect to other tissues, we 
performed differential expression analysis. Of the 152,952 TCs expressed in the 
FANTOM5  tissue  collection,  55,033  (36.0%)  were  differentially  expressed;  in 
particular, one third had higher expression in brain (18,626 TCs, mapping to 3,928 
distinct  genes;  genomic  coordinates  ,  fold-changes  and  p-values  provided  in 
Supplementary Table 2) (Figure 2a) and will be referred to as Brain-up in the rest 
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of the manuscript, to indicate that they are up-regulated in brain. 
We first investigated the general differences in genomic context between the two 
sets  of  TCs,  up-regulated  and  down-regulated  in  brain  tissues.  Comparing 
GENCODE  annotations  gave  similar  proportions  of  known  TSS,  coding 
sequences, antisense or intergenic signals. However TCs with higher expression 
in brain were slightly more likely to be distal to annotated TSSs (between 500 and 
1000  bps  upstream)  or  3'UTR-derived  (Supplementary  Figure  4).  As  deep 
sequencing of the human brain transcriptome has not been done previously to the 
same extent, these differences may reflect transcripts up-regulated in CNS that 
currently  lack  accurate  gene  models.  It  was  previously  reported  that  genes 
expressed in brain are frequently located in CpG rich regions (Roider et al. 2009): 
consistently with this observation, 5,811 (31.2%) of the brainUp TCs were located 
in CpG islands, as opposed to 7,642 (21.0%) in the down-regulated group (p < e-
16, Fisher exact test).  It  has also been suggested that brain tissues express a 
distinctive repertoire of repeats (Faulkner et al. 2009; Xu et el. 2010; Tyekucheva 
et al. 2011): in general we observed a sightly larger proportion of brainUp TCs 
overlapping repeats (18.9% vs. 13.1%). In particular, a remarkably large proportion 
of brainUp TCs overlapped simple and low complexity repeats (59.0% of brainUp 
TCs,  as  opposed to  26.5%),  while  there  were  less  expressed LTRs (8.8% as 
opposed to 34.4%, Figure 2b). There was no overall difference in the number of 
expressed Long and Short Interspersed Elements (LINE and SINE respectively); 
however  a  significant  difference  was  observed  in  the  relative  proportion  of 
expressed Alu (in the SINE family) and L1 (in the LINE family) repeats (Figure 2c).
Genes containing TCs up-regulated in brain were highly enriched in GO Biological 
Process terms and KEGG pathways related to brain function (Figure 3 a and b) as 
well as Genetic Association Database diseases such as schizophrenia, epilepsy 
and alcohol dependence (full list of enrichments provided in Supplementary Table 
3).  Looking at candidates that might have an important impact at the regulatory 
level, we investigated brainUp transcription factors and lncRNAs, with the specific 
aim of identifying novel elements that could be of interest for future research on 
genes involved in the establishment and/or maintenance of CNS transcriptional 
specificity. We identified 520 brainUp TCs mapping to transcription factors (183 
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genes):  these  included  several  examples  of  genes  with  critical  roles  in  the 
development of the CNS such as  TBR1, required for early cortical development 
(Bulfone et  al.  1995),  ZIC1 and  ZIC4, fundamental  for  cerebellar  development 
(Blank et al. 2011),  BHLHBE22, involved in neocortex development (Joshi et al. 
2008). The most highly expressed TF was TSC22D4 (Figure 3c), suggested to be 
important  for  granule  cells  differentiation  in  mouse  (Canterini  et  al.  2012). 
Importantly, we also found several brainUp TFs with unknown function, such as 
the  poorly  characterized  Zinc  Finger  proteins  ZNF25,  ZNF273,  ZNF302 and 
several others (the full list of brainUp TCs mapping to TFs ranked by expression in 
the CNS is provided in Supplementary Table 4). Interestingly some of these have 
recently been shown to be relevant for major diseases: HIVEP3, shown to be an 
essential regulator of adult bone formation (Jones et al. 2006) was suggested as 
candidate gene for the PARK10 locus associated to Parkinson's Disease (Li et al. 
2007);  PRDM8 was recently indicated as the causal  protein of  the early onset 
Lafora disease, a type of progressive myoclonus epilepsy (Turnbull et al. 2012), 
ZNF385D  was  recently  linked  to  reading  disability  and  language  impairment 
(Eicher et al. 2013) and negative symptoms in schizophrenia (Xu et al. 2013); TEF, 
associated with sleep disturbances and depression in Parkinson's disease patients 
(Hua et al. 2012; Hua et al. 2012). We identified 419 brainUp TCs mapping to 206 
distinct  lncRNAs  (full  list  of  brainUp  TCs  mapping  to  lncRNAs  ranked  by 
expression in the CNS is provided in Supplementary Table 4). Only two of them 
corresponded to known genes: the maternally imprinted genes  MEG3 and  H19. 
The remaining lncRNAs, such as the most highly expressed in brain (AC073479.1, 
Figure  3d)  had  no  known  annotation;  intriguingly,  however,  unsupervised 
clustering based on their expression profiles identified four groups of regions with 
related  developmental  derivation,  function  and/or  projections  (Figure  3e):  1) 
cerebellum, 2) cortex along with amygdala and hippocampus (cortex-limbic system 
group), 3) caudate and putamen (striatum), thalamus, globus pallidus, substantia 
nigra,  locus  coeruleus,  spinal  cord  and  medulla  oblongata  (brain  stem-basal 
ganglia group). Similarly, clustering based on expression of brainUp TCs mapping 
to TFs identified the same four groups of regions (Figure 3f), suggesting that these 
lncRNAs and TFs up-regulated in brain have functional relevance in the biology of 
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these regions.
Region specific transcription in the adult
In  order  to  assess  individual  differences  in  expression  across  distinct  brain 
regions,  we  performed  differential  expression  analysis  and  identified  9,758 
differentially expressed TCs, mapping to 3,891 genes. The region with the largest 
number of differentially expressed TCs was cerebellum (Figure 4a), possibly due 
to the fact that it is characterized by the highest neuron to glia ratio in the CNS 
(Azevedo et al. 2009). Besides this case and consistently with previous reports 
(Hawrylycz et  al.  2012)  we didn't  identify  expression signatures that  univocally 
define single regions, but rather observed four major expression patterns shared 
across multiple regions, in a way that mimics what we saw for transcription factors 
and lncRNAs up-regulated in brain (Figure 4b). Based on this evidence, we used 
k-means clustering to separate the differentially expressed TCs into four mutually 
exclusive co-expression modules that we named according to the regions they 
represent (Table 3, Supplementary Figure 5). As expected, in each of them we 
found TCs mapping to genes that are known markers for the anatomical groups of 
regions they represent. For example in the cortex-limbic system group we fond the 
genes  FXYD6,  CCK and  CBLN2,  markers  for  cortex  layers  2/3/6  (Zeng et  al. 
2012);  the  markers  for  granule  cell  progenitors  MEIS1,  PAX6,  ZIC1 and  ZIC2 
(Salero and Hatten 2007) were consistently assigned to cerebellum; the striatum 
markers SST, DRD1 and DRD2 were found in the striatum group. The brain stem - 
basal ganglia group is clearly the most heterogeneous, however we found in this 
group  enzymes  involved  in  the  production  of  specific  products  that  are  only 
synthesized in some of  the regions in this group such as  TH,  DDC and  DBH. 
Additionally we found in this group important components of myelin such as PLP, 
MOG and  MBP,  suggesting  enrichment  in  these  regions  for  glial  cell  types. 
Interestingly  and  consistently  with  our  previous  observations  on  genes  up-
regulated in brain, specific sets of TFs were expressed in each of the four groups 
(full  information  provided  in  Supplementary  Table  5).  For  example,  several 
members  of  the  HOX genes,  a  highly  conserved  gene  family  involved  in  the 
definition  of  antero-posterior  patterning  during  embrionic  development,  were 
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assigned to the brain stem – basal ganglia group;  ARNT2, a member of bHLH-
PAS TF family linked to nervous system development and previously described as 
a key factor in mouse hippocampus gene regulation (Valen et al. 2009) belonged 
to  the  cortex-limbic  system  group.  Using  STRING  (http://string-db.org/),  a 
database of  protein-protein  interactions (PPI)  based on genomic context,  high-
throughput experiments, co-expression and literature (Szklarczyk et al. 2011) we 
could  confirm  known  interactions  for  a  large  number  of  the  TFs  in  each  set  
(Supplementary Figure 6), which suggests that novel connections in each group 
will be possibly discovered with future research.
Since  regionally  biased  expression  of  coding  genes  has  been  described 
extensively  (Kang  et  al.  2011;  Hawrylycz  et  al.  2012),  we  focused  on  the 
expression patterns of TCs mapping to poorly characterized transcript classes and 
genomic regions. In the set of differentially expressed TCs, 1,769 (18.1%) mapped 
to  non-protein  coding  transcripts  and  included  different  biotypes;  the  most 
represented  classes,  accounting  for  85.1%  of  the  non-coding  fraction,  were 
processed  transcripts,  retained  introns  and  lncRNAs (Figure  4c).  Examples  of 
lncRNAs with regionally biased expression patterns included the uncharacterized 
transcripts RP11-307B23.1 (brain stem-basal ganglia), RP11-59J5.1 (cerebellum), 
MIR7-3HG,  AC113617.1  and  RP11-60A8  (cortex-limbic  system),  CTA-929C8 
(striatum)  (the  full  list  of  region  specific  TCs  mapping  to  lncRNAs  and 
corresponding  annotations  is  provided  in  Supplementary  Table  6).  Of  the 
differentially expressed TCs mapping to poorly characterized transcript classes, 
544  (5.6%)  were  intergenic,  indicating  potential  new  coding/non-coding  genes 
and/or alternative TSSs. Using the histone H3K4me3 ChIP-seq dataset published 
in (Shulha et al. 2013), we found that 49.1% of these intergenic TCs overlaps the 
H3K4me3  signature,  percentage  that  increased  to  74.1%  when  restricting  to 
intergenic  TCs  belonging  to  the  cortex-limbic  system  group,  supporting  the 
hypothesis that they mark TSSs of novel transcripts. A very interesting example of 
how these intergenic signals can represent novel transcripts is shown in Figure 5d.  
We identified a set of cerebellum-specific TCs in an intergenic region located 850 
kb downstream to the gene KCNJ3, a potassium channel gene that belongs to the 
cerebellum group and has a suggestive implication with epilepsy (Chioza et al. 
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2002). RNA-seq expression data available for one of the adult cerebellum samples 
included in this study suggests the presence of a 140 kb novel transcript located 
ca.  850 kb  downstream to  the  gene  KCNJ3.  Interestingly,  the  genomic  region 
comprising of the novel transcript and the last exon of  KCNJ3 was found to be 
deleted in two patients affected by developmental disorders with language delay 
and  communication  difficulties,  for  which  a  conclusive  causal  variant  was  not 
identified (Newbury et al. 2009).
Discussion
In this study we generated a comprehensive atlas of transcription start sites for the 
human central nervous system, by sequencing at high depth (5 million reads per 
sample on average) CAGE libraries for 15 anatomically distinct regions of the CNS 
(Table 1). We identified 95,912 TCs, supporting the expression of 19,018 coding 
and non-coding genes, as annotated in Gencode v10. With this resolution, we 
broaden the landscape of brain gene expression: e.g. (Kang et al. 2011) reported 
the expression of 15'132 mainly coding genes in at least one region/developmental 
stage, while our previous study on a limited set of brain regions (Pardo et al. 2013) 
reported 16'888. It is likely that this increase is due to a combination of broader set  
of  regions  profiled,  use  of  an  annotation-independent  profiling  technique  and 
extremely high sequencing depth. In particular we identified 4,779 intergenic TCs 
that represent bona fide novel transcripts. Notably 34.5% of them were supported 
by ChIP-seq H3K4me3 signature (marking sites of active transcription) derived 
from frontal lobe nuclei (Shulha et al. 2013): it is likely that with matched data this 
percentage would increase to 100%. Additionally an important fraction of the TCs 
for which we detect expression in brain (12.0%) maps to processed transcripts and 
retained  introns,  i.e.  mainly  representing  non-coding  transcripts  associated  to 
coding genes. This finding couples with recent publications (e.g. ENCODE Project 
Consortium 2012) demonstrating that pervasive transcription is a common feature 
of mammalian genomes. Although the functional meaning, and perhaps relevance, 
of this type of transcripts is under scrutiny and will require years of work to be  
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dissected, most likely at least part of them are functionally relevant, as suggested 
by the fact that 1.  they contribute in setting apart  CNS from other tissues and 
(Supplementary  Figure  3)  and  2.  they  show  regionally  biased  patterns  of 
expression that is comparable to that of coding genes. Additionally, these classes 
of  poorly  characterized  transcripts  contribute  to  the  outstanding  transcriptional 
complexity of CNS tissues (Supplementary Figure 2). The idea that brain structural 
and functional complexity is reflected at the transcriptional level was suggested in 
other  studies  before,  such  as  (Jongeneel  et  al.  2005).  Our  data,  based  on  a 
broader range of CNS and non-CNS samples supports this intriguing hypothesis. 
This is likely to reflect a combination of both the complex mixture of cell types in  
human  nervous  tissues  (neurons,  glial  cells,  blood  vessels,  microglial  cells, 
macrophages etc.) and the rich set of novel brain specific transcripts, including 
those derived from repeat regions. The specificity and distinctiveness of CNS is 
clearly  shown  in  our  study  (Figure  1,  a-d),  and  it  involves  several  layers  of 
trancription:  it's  true  at  the  level  of  coding  genes,  suggesting  a  structural  
component,  it's  true  at  the  level  of  established  and  potential  regulators 
(transcription  factors  and  lncRNAs),  and  it  holds  true  for  the  putative  novel 
transcripts  we identify.  Interestingly  on the same lines (Andersson et  al.  2014) 
show  that  enhancer  expression  clearly  group  CNS  tissues  apart  from  other 
tissues. A feature of brain transcriptome that could be related to its complexity lies 
in  expressed repeat  regions,  which have been linked to  the evolution of  gene 
expression and its regulation (Lynch et al. 2011). We show that TCs up-regulated 
in  brain,  in  general  slightly  more  often  derived  from repeats  than  TCs  down-
regulated in brain, are impressively enriched in simple and low complexity repeats 
and depleted of LTRs (Figure 2b). Similar observations were previously reported 
(Faulkner  et  al.  2009;  Xu et  el.  2010;  Tyekucheva et  al.  2011)  and our  study 
confirms  that  this  is  a  specific  feature  of  brain  transcription.  Additionally,  we 
observed a significantly higher number of Alu (SINE family) and L1 (LINE family) 
repeats (Figure 2c) up-regulated in brain. This is particularly interesting as active 
somatic retrotransposition was described in the neural cell lineage and shown in 
particular to be a feature of mature human brain (Baillie et al. 2011).
A class of non-coding transcripts that is gaining rising attention is the group of 
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lncRNAs. Very few of them have been characterized in detail so far but there is 
increasing  evidence  of  their  fundamental  involvement  in  several  biological 
processes,  e.g.  a  lncRNA was  recently  described  to  regulate  in  mouse  the 
translation of UCLH1 (Carrieri et al. 2012). We identified over a thousand lncRNAs 
expressed in the CNS (1,407); in particular 419 were up-regulated in brain. This is 
an extremely valuable part of our dataset, completely unexplored and unknown, 
but potentially extremely relevant. Intriguingly, clustering of brain samples based 
on this subset of the data showed that these lncRNAs up-regulated in brain are 
expressed  in  a  regionally  biased  manner  (Figure  3e).  The  same  observation 
applied for transcription factors (Figure 3f), raising the intriguing hypothesis that 
they coordinately  regulate  region-specific  transcriptional  programs.  Interestingly 
several of the TFs up-regulated in the adult brain were known to have key roles 
during  brain  development,  suggesting that  some of  the poorly  annotated ones 
might have similar roles.
We were not able to identify expression signatures specific for every single region 
included in this study, probably because we are measuring average expression 
profiles in a very heterogeneous cellular population. This sounds particularly true 
in light of recent reports showing that mosaic copy number variants are a common 
feature  in  human  (McConnell  et  al.  2013)  and  drosphila  (Perrat  et  al.  2013) 
neuronal cell types. Future applications in brain transcriptomics will surely benefit  
of the recent advances in single-cell profiling. However, consistently with previous 
reports (Kang et al. 2011; Hawrylycz et al. 2012) we identified transcription profiles 
that tend to be similar between developmentally, functionally or morphologically 
related regions, with cerebellum showing the most distinctive expression signature 
and the largest number of differentially expressed TCs (Figure 4a). At the level of  
protein coding transcripts we find TCs mapping to known molecular markers for 
these regions, and we find considerable differences in expression of transcription 
factors, but similar to other analyses in this work, we want to highlight the large 
proportion (18.2%) of the differentially expressed TCs corresponding to non-coding 
transcripts. 
Overall  our  findings clearly  demonstrate  the  importance and power of  using  a 
completely  unbiased  approach  to  profile  transcription.  While  projects  such  as 
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ENCODE have provided a wealth of new data on the transcriptional landscape of 
our genome, our finding that a substantial portion of transcription is brain specific 
and region specific clearly demonstrates the need to complement the available 
data with data directly derived from tissues. Moreover, the discovery that poorly 
annotated  and  non-coding  transcripts  significantly  contribute  to  the  specific 
transcriptional programs shows that functional annotation is still a long way to go. 
Our data therefore provides the scientific community with an important resource 
for interpreting the available genetic findings and provide testable hypotheses that 
can be followed up in the laboratory.
Materials and methods
Tissues, CAGE library preparation and sequencing.
RNA was extracted from post mortem brain tissues obtained from the Netherlands 
Brain  Bank  (NBB;  Amsterdam,  The  Netherlands).  The  donors  were  subjects 
without clinical signs of neurodegenerative or psychiatric disorders; age at death is 
reported in Supplementary Table 1. All brains were neuropathologically evaluated 
by  an  experienced  neuropathologist  and  classified  for  neurofibrillary  tangles 
(NFTs)  stage 0-VI  (Alafuzoff  et  al.  2008),  amyloid-beta plaques score 0-C and 
Braak  -synuclein  stages 0-6  using  the  staging  protocols  of  Brain  Net  Europe  
(BNE) and Braak (Alafuzoff et al. 2009, Alafuzoff et al. 2009, Braak et al. 2006). 
The  dissection  of  all  regions  was  performed  from  snap  frozen  human  brain 
sections.  Tissue  was  stored  at  -80oC until  further  processing.  Total  RNA was 
extracted  and  purified  from  tissues  using  the  Trizol  tissue  kit  according  to 
instructions provided by the manufacturer (Invitrogen). RNA quality was assessed 
using the RNA Integrity Number (RIN) with the Agilent Total RNA Nano kit. All the 
samples used, their  RIN values and library IDs are included in Supplementary 
Table 1.  All  the libraries were sequenced using the  Heliscope single molecule 
sequencer. Library preparation and tag extraction were performed as described in 
(Forrest et al. 2014).
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Mapping, clustering and annotations.
General data processing on the extracted tags was performed by the main project 
and is detailed in (Forrest et al. 2014). Briefly the steps include: 1. removal of the  
reads mapping to ribosomal RNA; 2. mapping of the remaining reads to the human 
genome (hg19 built) using the probabilistic mapping tool Delve; 3. removal of the 
tags with  low mapping quality  or  mapping to  the  genome with  less  than 85% 
identity;  4.  clustering  of  the  CAGE  tags  into  tag  clusters  (TCs)  using  the 
decomposition-based  peak  identification  method  (DPI.  Kawaji  et  al.  In 
preparation).  Annotation files were built  in  the context  of  the main project  and 
provided for each TC annotation information with respect to Gencode v10 gene 
model, CpG islands, TATA box and repeats from Repeat Masker in bed format.  
Expression  tables  containing  tag  counts  and  RLE  (Relative  Log  Expression) 
normalized expression values were built by the main project (Forrest et al. 2014); 
when  the  expression  “tpm”  is  used  in  the  text,  we  refer  to  RLE  normalized 
expression values. In this work a TC was considered to be expressed in brain if it  
counted at least 1 tpm in at least one of the brain libraries used; similarly a cluster 
was considered to be expressed in the FANTOM5 tissue collection if it counted at 
least 1tpm in at least one of the libraries in the collection.
H3K4me3 ChIP-seq data from post mortem cortex.
Data  presented  in  (Shulha et  al.  2013)  was  downloaded  from 
http://zlab.umassmed.edu/zlab/publications/ShulhaPLOSGen2013.html.  Only 
neuronal ChIP-seq samples with ages comparable to the adult donors in this study 
were included in the analysis (samples c25 to c31, average age 70 years). Peak 
calling  was performed on  each sample  using  MACS (Zhang et  al.  2008)  with 
parameters -bw=230 and -t=36 and using the input control available from (Shulha 
et al. 2013). A pool of 33,305 peaks was created considering all peaks called in at 
least one sample and merging adjacent peaks. Intersections were performed using 
windowBed (bedTools suite, Quinlan and Hall 2010), with a window size of 500 
base pairs.
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Multidimensional scaling.
Multidimensional Scaling (MDS), also known as principal coordinates analysis, is a 
data reduction technique similar to principal component analysis that can be used 
to visually represent the similarities (or differences) among a set of objects, in this 
case expression profiles.  The MDS plots  shown in  this  paper  were  performed 
using  the  R  function  cmdscale(). The  matrix  of  pairwise  euclidean  distances 
between expression profiles used as input for the MDS plots was created with the 
R function dist() on log-transformed normalized data.
Identification of TCs up-regulated in brain.
To identify TCs up-regulated in brain we used the Bioconductor package edgeR 
(Robinson et al.  2010),  dividing the samples of the FANTOM5 tissue collection 
(Supplementary Table 1) into two groups, that we named "brain" and "other". TCs 
satisfying the criteria “FDR < 1% after Benjamini-Hochberg correction and |logFC| 
> 2” were considered differentially expressed between brain and other tissues. The 
TFs annotations used are provided in the as supplementary material of (Forrest et 
al. 2014). Expression heatmaps were performed using the R package gplots.
Functional annotation.
GO Biological Process and KEGG enrichment analysis on the genes up-regulated 
in brain was performed with DAVID (Sherman et al. 2007), using as background all 
the genes expressed in the reference set of brain samples. All the enrichments 
with FDR < 1% are reported in Supplementary Table 3.
Identification  of  TCs  differentially  expressed  across  regions  and  shared  
patterns of differential expression.
To  identify  TCs  differentially  expressed  across  regions  we  divided  the  CNS 
libraries into 15 groups (one for each of the brain regions under analysis) and used 
edgeR to perform the differential expression analysis (significance threshold: p-
value  <  0.01%  after  Benjamini-Hochberg  correction  and  |logFC|>2).  We  then 
combined the results of the pairwise comparisons requiring p-value < 0.01 after 
additional Bonferroni correction to adjust for multiple testing. To identify patterns of 
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expression shared between different brain regions we defined a matrix of “region-
specificity” scores defined as “log(average tpm in region) - log(average tpm across 
all  brain  samples)”.  Finally,  we  used  the  R  (http://www.r-project.org/) 
implementation of the clustering algorithm k-means to partition the matrix into four 
groups that capture the major co-expression patterns observed (Supplementary 
Figure 5). These scores were used to create the heatmap in Figure 4b, performed 
using the R package gplots.
Data Accessibility.
All the data used in this paper is accessible through ZENBU, a fast, user-friendly 
and highly customizable genome browser (Severin et al. Submitted). Cell type and 
co-expression cluster specific annotations, motifs and transcription factors can be 
explored through the FANTOM5 Resource Browser (Shimoji et al. In preparation) 
and the FANTOM5 main portal available at http://fantom.gsc.riken.jp/5/top/ (note to 
reviewers: the portal  will  be freely available after the main FANTOM5 paper is 
published). These resources and related references are described in more detail in 
(Forrest et al. 2014).
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Figure  1.  Transcriptional  specificity  and  complexity  of  the  human  brain 
transcriptome.
a.-d. Multidimensional  scaling  representation  of  all  TCs  expressed  in  the 
FANTOM5 tissue collection for four subsets of the data, representing coding genes 
(a), transcription factors (b), lncRNAs (c) and putative novel transcripts (d). Brain 
samples  (in  grey)  clearly  separate  from other  tissues (in  black)  based on the 
expression profiles of all the subsets. The 9 samples that deviate from the tissue 
cluster  in  the  direction  of  brain  in  (a)  are:  cerebrospinal  fluid,  vitreous  humor, 
adipose  tissue  (donors  1  to  4),  fetal  eye,  adult  testis  and  adult  retina.  The  7 
samples closest to brain at the level of TFs expression (b) are adult retina, fetal  
eye, adult testis and adipose tissue (donors 1 to 4). The two samples that deviate 
from both the CNS and the other tissues based on lncRNA expression are adult 
testis.  e. Cumulative distribution of tags accounted for by the top 10,000 most 
highly expressed TCs for all the tissues in the FANTOM5 collection. The curves 
representing  brain  samples,  in  red,  group  in  the  lower  part,  indicating  higher 
transcriptional complexity.  f. Comparison of N50 values (number of TCs required 
to cover at least 50% of the library, providing a quantification of the curves in e.) 
counts  for  brain  and  other  tissues,  showing  that  brain  has  significantly  higher 
transcriptional complexity with respect to other tissues.
Figure 2. The genomic context of TCs up-regulated in brain.
a. 36%  of  the  TCs  expressed  across  the  FANTOM5  tissue  collection  are 
differentially expressed between brain and other tissues; in particular 18,626 TCs 
are  up-regulated in  brain.  b. Fraction  of  TCs up-  and down-regulated in  brain 
(represented  in  red  and  blue  respectively)  mapping  to  a  range  of  repetitive 
elements: TCs up-regulated in brain are clearly enriched in expressed simple and 
low complexity repeats, while they are depleted in LTRs.  c. Relative number of 
expressed Alu and L1 repeats over the total number of expressed SINE and LINE 
respectively:  TCs up-regulated in  brain  tend to  be more frequently  Alu-  or  L1-
derived with respect to TCs down-regulated in brain.
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Figure 3. Up-regulated TCs in brain map to genes involved in brain function 
and to TFs and lncRNAs that are expressed in region-specific patterns.
a. 10 most significantly enriched GO Biological Process terms in the set of genes 
up-regulated in brain: on the left side are reported the GO terms, the length of  
each bar represents significance (as -log(FDR)), the numbers at the end of the 
bars  represents  the  number  of  genes  up-regulated  in  brain  that  map  to  the 
corresponding  GO  term.  b. Similar  representation  as  a.  performed  for  KEGG 
pathways. The full list of enrichments are provided as supplementary material.  c. 
The  TF  up-regulated  in  brain  with  highest  expression  is  the  transcriptional  
repressor  TSC22D4. It's interesting to note that brain and other tissues express 
distinct isoforms that differ in their exon content. d. The up-regulated lncRNA with 
highest expression in brain tissues is  AC073479.1, located in the chromosomal 
band 2p25.2. e. Heatmap representation of the expression profiles of the lncRNAs 
up-regulated in brain:  each row represents a single TC and the corresponding 
expression,  each  column  represents  one  sample.  The  colours  of  the  top  bar 
summarize the clustering of the brain regions into the four groups induced by the 
expression profiles of the TCs included in the heatmap (i.e. all TCs mapping to 
lncRNAs).  f. Similarly as e. heatmap representation of the expression profiles of 
the TCs up-regulated in brain mapping to TFs.
Figure 4. Differential expression across brain regions.
a. Number of TCs identified as differentially expressed in each of the brain regions: 
cerebellum is characterized by the largest number of differentially expressed TCs 
(y axis indicates the number of differentially expressed TCs). Note that a cluster 
can be differentially expressed for more than one anatomical region. b. Heatmap 
representing the expression patterns of the TCs differentially expressed across 
regions. Each row represents a single TC and the corresponding expression on a 
per-region basis, showing that expression signatures are not characteristic of a 
single region but tend to be shared, suggesting a separation into four major groups 
of anatomical regions (top dendrogram). The four groups are summarized through 
the color bar below the dendrogram. c. Distribution of the biotypes of non-coding 
transcripts associated to CAGE TCs differentially expressed across brain regions. 
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The  top  represented  classes  are  processed  transcripts,  retained  introns  and 
lncRNAs,  accounting  together  for  over  85%  of  all  the  differentially  expressed 
clusters  mapping  to  non-coding  transcripts.  d. Example  of  cerebellum specific 
intergenic cluster with RNA-seq support. This novel transcript is located ca. 850 kb 
downstream  to  the  gene  KCNJ3,  over-expressed  in  cerebellum  as  well.  The 
genomic region comprising of the novel transcript and the last exon of the gene 
KCNJ3 was  found  to  be  deleted  in  two  patients  affected  by  developmental 
disorders with language delay and communication difficulties (see main text).
Table 1. Regions of the CNS included in the study.
Region name Abbreviation used in the plots
Amygdala amy
Caudate caud
Cerebellum cer
Globus pallidus glP
Hippocampus hip
Locus coeruleus locC
Medial Frontal Gyrus MFG
Medial Temporal Gyrus MTG
Medulla Oblongata medO
Occipital Cortex occC
Parietal Cortex parC
Putamen put
Spinal Cord spC
Substantia Nigra subN
Thalamus thal
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Table 2: Summary of distribution of TCs.
Number
TCs Expressed across all human tissues 122938
Expressed in human brain 91643
Brain-specific 26035
Coding Genes Total number in all human tissues 93822 (76.3%)
Expressed in human brain 72017 (78.6%)
Brain-specific 19403 (74.5%)
Non-coding Total number in all human tissues 21621 (17.6%)
Expressed in human brain 15214 (16.6%)
Brain-specific  4695 (18.0%)
Unannotated Total number in all human tissues  7495 (6.1%)
Expressed in human brain  4412 (4.8%)
Brain specific  1937 (7.4%)
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Abstract
The  mouse  and  human  brain  express  a  large  number  of  noncoding  RNAs 
(ncRNAs). Some of these are known to participate in neural progenitor cell fate 
determination,  cell  differentiation,  neuronal  and  synaptic  plasticity  and 
transposable  elements  derived  ncRNAs  contribute  to  somatic  variation. 
Dysregulation  of  specific  long  ncRNAs  (lncRNAs)  has  been  shown  in  neuro-
developmental and neuro-degenerative diseases thus highlighting the importance 
of lncRNAs in brain function. Even though it is known that lncRNAs are expressed 
in cells at low levels in a tissue-specific manner, bioinformatics analyses of brain-
specific  ncRNAs  has  not  been  performed.  We  analyzed  previously  published 
custom microarray ncRNA expression data generated from twelve human tissues 
to  identify  tissue-specific  ncRNAs. We find that  among the 12 tissues studied, 
brain has the largest number of ncRNAs. Our analyses show that genes in the 
vicinity  of  brain-specific  ncRNAs  are  significantly  up  regulated  in  the  brain. 
Investigations  of  repeat  representation  show  that  brain-specific  ncRNAs  are 
significantly more likely to originate in repeat regions especially DNA/TcMar-Tigger 
compared  with  non-tissue-specific  ncRNAs.  We  find  SINE/Alus  depleted  from 
brain-specific dataset when compared with non-tissue-specific ncRNAs. Our data 
provide  a  bioinformatics  comparison  between  brain-specific  and  non  tissue-
specific ncRNAs. 
Introduction
Long noncoding RNAs (lncRNAs) are generally regulatory in nature, modulating 
transcriptional silencing through chromatin modification2, 3, transcriptional activation 
due to gene proximity  4 or enhancer function  5,  6 or participating in up-regulating 
protein  translation  through  inverted  repeats  sequences  as  in  UCHL11.  Initially 
lncRNAs  were  defined  as  transcripts  longer  than  200  nucleotides  that  were 
incapable of coding for more than 100 amino acids  [59]. This arbitrary definition 
was contradicted by the demonstration of functional polypeptides shorter than 100 
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amino acids 7, the evidence that lncRNAs harbor open reading frames (ORFs) and 
the  discovery  of  bi-functional  RNAs  which  not  only  produce  proteins  but  also 
function as regulatory lncRNAs 8-12. Interrogation of whole transcriptomes of cells 
by the ENCODE consortium has revealed that even though 62% of the genomic 
bases  are  reproducibly  represented  in  transcribed  long  RNA  molecules  or 
GENCODE exons, only 2.94% are represented in GENCODE annotated exons of 
protein coding genes )13-15. A large proportion of the human genome appears to 
generate RNAs at low expression levels, 80% of lncRNAs transcripts and 25% of 
protein coding (pc) transcripts are detected at 1 copy (or less) per cell suggesting 
that the expression of nc transcripts may be limited to subpopulations of cells  15. 
These nc transcripts are generally located within the nucleus, may be adenylated 
or polyadenylated and originate from intergenic as well as genic loci  15, 16. Based 
on data generated in the ENCODE project, a GENCODE v7 catalogue has been 
created for human lncRNAs containing 14,880 non coding transcripts arising from 
9,277  ncRNA genes  16.  Investigation  of  peptide  signatures  through  MS  /  MS 
analyses revealed that  92% of  lncRNAs listed in the GENCODE v7 catalogue 
have no protein coding competency 17. While most lncRNAs are bioinformatically 
derived, their functional evaluation is difficult due to their low levels of expression 
and absence of defined landmarks such as sequence similarities. 
Due  to  the  fact  that  lncRNAs display  a  lower  level  of  sequence  conservation 
across species  32,  33,  investigations on lncRNA expression and function call  for 
species-specific  analyses.  For  example,  the  2  kb  long  multifunctional  lncRNA 
HOTAIR can  potentially  silence  hundreds  of  gene  targets  via  independent 
interactions with the PRC2 and LSD1 complexes  34 and is required for silencing 
genes within the HOXD cluster  35 and in determining the metastatic potential of 
breast  36 and  nasopharyngeal  cancers  37 in  humans  but  in  mouse,  hotair is 
structurally different and displays no functional  similarities to human  HOTAIR38. 
Although RNA-seq has been largely instrumental in the discovery, assembly and 
annotation of the current catalogue of lncRNAs, due to the low expression levels of 
ncRNAs and the depth required to  rule out  false negatives,  it  is  impractical  to 
utilize sequencing to ascertain the presence of lncRNAs in tissues to generate 
tissue-specific ncRNA datasets [16; 39]. Further, due to strict size selection during 
98
current library preparation protocols, it is difficult to conduct combined analyses of 
long and short RNAs using RNA-seq datasets [3; 16]. Overall microarray platforms 
are  better  suited  for  studies  designed  to  detect  the  presence  or  absence  of 
annotated long and short ncRNAs across tissues 16, 39.
RNA-seq  and  custom  lncRNA microarray  analyses  of  multiple  human  organs 
suggest  that  lncRNAs  display  higher  tissue-specificity  compared  with  pc 
transcripts 16 [60]. This appears to be particularly true for the mouse brain where 
lncRNA expression is reported to be region-specific as shown in Mercer et al  18 
who extracted 849 ncRNAs from the Allen Brain Atlas in-situ hybridization assays 
and  found  neuro-anatomical  and  cell  subtype-specific  expression  in  the  adult 
mouse brain  18.  Many studies on lncRNAs and their function and dysregulation 
have focused solely on the brain and brain related disorders.  Recent literature 
suggests  that  ncRNAs  play  a  vital  role  in  the  brain  [61]  not  only  during 
development  19 20 [62;  63;  64],  neural  stem  cell  differentiation  21 and  protein 
translation at synapses, but also contribute to higher order functions such as long-
term memory formation 22 and synaptic plasticity 20, 23 24, 25. Dysregulation of specific 
ncRNAs has been shown in neurodegenerative diseases with cognitive decline 
such as Alzheimer's disease, Parkinson’s disease and Huntington’s disease 26-28; 29, 
30. Further, short processed ncRNAs are also known to affect brain function and 
are expected to be dysregulated in diseases  31.  Two independent studies have 
identified lncRNAs expressed in the mouse 18, 20 and human brain 18, 20, however it 
is  not  known  if  all  these  lncRNAs  are  functional  or  if  they  are  expressed 
exclusively in the brain.  Our aim in this study is to identify ncRNAs expressed 
solely in the brain and investigate them bioinformatically, to uncover distinctions 
from ncRNAs that are expressed in more than one tissue. 
Nielsen  et  al  designed  60  nucleotide  custom  microarray  probes  for  26,910 
potentially functional ncRNAs of size greater than 60 nucleotides extracted from 
various  databases  39.  They  selected  ncRNAs  probes  based  on  conservation, 
expression and active chromatin marks and determined the presence or absence 
of these ncRNAs in 12 human tissues 39. After discarding probes that mapped to 
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mitochondrial  RNAs,  pseudogenes  and  those  probes  that  multi-mapped  to 
repeats, they identified a set of 12,115 ncRNAs of which 3,513 were expressed in 
at  least  1 tissue above background. We analyzed this microarray dataset  39 to 
identify ncRNAs expressed in a single tissue. Our data show that among the 12 
tissues studied, brain harbors the largest number of single tissue ncRNAs, which 
we call brain-specific ncRNAs. Further analyses of brain-specific ncRNAs reveal 
that they are longer than 200 nucleotides and map close to genes up regulated in 
the brain.  Analyses of repeats in their  transcript  body reveal  that  brain-specific 
ncRNAs originate more often in repeats and are likely to be depleted in SINE/Alu. 
Brain-specific ncRNAs are located in the vicinity of genes up regulated in 
the brain
We analyzed the microarray dataset from Nielsen et al to identify ncRNAs whose 
expression was restricted to a single tissue and found that brain had the largest 
number of such ncRNAs (n=303) (Table 1, Figure 1a). We refer to this dataset as  
brain-specific  ncRNAs. To verify  that  the microarray dataset  used in  our  study 
captured ncRNAs missed by  RNA-seq,  we overlapped  brain  RNA-seq dataset 
from Wang et al (Nature 456 470-476) with our microarray based brain-specific 
ncRNAs dataset derived from Nielsen et al (ref). Our data show that out of 303 
brain specific ncRNAs, only 96 were found in the RNA-seq dataset, an overlap of 
32%  (Supplementary  Table  1  worksheet  overlap_microarray_RNA-seq).  For 
example  we  did  not  find  ncRNAs in  the  intron  of  Brain  specific  angiogenesis 
inhibitor 3 (BAI3), Neuroligin 1 (NLGN1), as well as ncRNAs distal to genes such 
as potassium voltage-gated channel (KCNH5) and Myelodysplastic syndrome 2 
translocation associated gene (MDS2) in the RNA-seq dataset. 
Since ncRNA transcription can affect the expression of nearby genes positively or 
negatively  4-6,  we extracted the pc genes nearest to the brain-specific ncRNAs 
from  GENCODE  v17  (Supplementary  Table  1  worksheet 
closest_gene_and_distance), which provided a list of 283 unique genes. In view of 
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a recent publication suggesting a positive correlation between the expression of 
ncRNAs and mRNAs within 20 kbs of each other [16], we selected protein-coding 
transcripts within 20 kb, thus limiting our analyses to 187 protein coding genes in 
the vicinity of 303 brain-specific ncRNAs 16. Expression analysis shows that 91 out 
of 187 pc genes (48.7%) were up-regulated in the brain (p-value <0.01, FDR 0.05) 
(Figure  1b,  Supplementary  Table  1  worksheet  upTissue_20-100kb). Next,  we 
conducted functional enrichment analysis on the 187 pc genes using DAVID to 
identify if they shared any similarities.  Investigation of the GO terms associated 
with  these  genes  failed  multiple  testing  thresholds  (Supplementary  Table  1 
worksheet GO_20kb). Extending our window to genes within 50 and 100 kb also 
failed  to  reveal  brain-specific  GO  terms  (Supplementary  Table  1  worksheets 
GO_50kb and GO_100kb). We also conducted STRING network analyses  40 to 
investigate if the pc genes within 20 kb were functionally related to each other. Our 
data failed to reveal widespread functional interaction between the genes in the 
vicinity of brain-specific ncRNAs (Figure 1c). 
Association of brain-specific ncRNAs with repeats
Almost  45% of  the  human genome is  made of  repeat  DNA sequences called 
transposable elements (TEs) or mobile elements 41, 42. TEs called retrotransposons 
are capable of being transcribed into partial or full length RNAs and transported 
into  the  cytoplasm  for  translation  of  specific  proteins.  These  proteins  reverse 
transcribe the retrotransposon RNA into DNA and insert it back into the human 
genome  42. The reverse transcription does not always extend to the end of the 
transcript resulting in partial, transpositionally incompetent copies inserted in the 
genome.  Due  to  the  potential  mutagenicity  caused  by  such  amplification, 
transpositionally competent full-length repeat elements are heavily methylated in 
adult  cells  43,  however  the transpositionally  incompetent  copies are abundantly 
represented in  the transcriptomes of  human and mouse cellsand suggested to 
have a role in transcriptional regulation 44. Intersection of TE catalogs with lncRNA 
databases has shown that TEs are represented in 83.4% of lcRNAs and merely 
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39.1% of protein coding RNAs 45. Recently, the retrotransposition competent TEs 
were shown to be active in differentiating neural progenitor cells  46 and in adult 
brain  47, 48 thus making a case for somatic insertion events in mouse and human 
brain.  Among all  tissue-specific  ncRNAs identified  in  this  study,  brain  had  the 
highest number of specific ncRNAs originating within 100 bp of a repeat element  
followed  closely  by  muscle  (Supplementary  Table 
2_Repeats_at_origin_tissue_wise). Comparison of brain-specific and non-tissue-
specific  ncRNAs  (ncRNAs  expressed  in  more  than  1  tissue)  showed  that  a 
significantly  higher  percentage  of  brain-specific  ncRNAs  originate  from  repeat 
regions (66.7% vs. 57.3%, p-value < 0.01) (Figure 2a, Table 2 and Supplementary 
Table 2, worksheet brain_repeats_at_origin). 
Since LTRs are reported as frequently found at the transcription start sites (TSSs) 
of long intergenic ncRNAs (lincRNAs) 44, 45, 49, 50 we investigated the representation 
of  major  repeat  families  at  the  TSSs  of  brain-specific  and  non-tissue-specific 
ncRNAs. Our data showed an abundance of LINE L1 and SINE Alu elements at 
the  TSSs  of  ncRNAs  (Figure  2b  and  Supplementary  Table  2  worksheets 
brain_repeats_at_origin  and  brain_repeat_names_at_origin).  Further 
investigations revealed that brain-specific ncRNAs were significantly enriched in 
DNA/TcMar-Tigger at origin in comparison with non-tissue-specific ncRNAs (p < 
0.05) (Table 2 and Supplementary Table 2 worksheet repeats_at_origin).
We also looked for raw number of repeats embedded within the body of brain-
specific  and  non-tissue-specific  ncRNAs.  We  found  that  91%  of  brain-specific 
ncRNAs harbor  repeats within  the transcript  body,  a  number marginally  higher 
than the non-tissue-specific ncRNAs (85.1%) (p < 0.01) (Figure 2c, Table 2 and 
Supplementary Table 2,  worksheet  intersecting_repeats_transcript).  Analyses of 
raw numbers of repeat families within transcript body showed that brain-specific 
ncRNAs were significantly depleted in SINE/Alu and SINE/MIR but enriched in 
LINE/L1,  LTR/ERVL  and  DNA repeats  in  comparison  with  non-tissue-specific 
ncRNAs  (p  <  0.001)  (Figure  2d,  Table  2  and  Supplementary  Table  2 
intersecting_repeats_transcript). To exclude inaccuracies resulting from the length 
of transcripts in this analysis, we repeated this analysis to investigate base pair 
coverage  by  repeat  families  in  both  datasets.  Our  data  show  that  despite 
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significantly  different  raw  numbers,  the  overall  percentage  of  repeat-derived 
sequence for brain-specific and non-tissue-specific ncRNAs is similar (49.8% vs. 
48.3% respectively) (Figure 2E). Family wise distribution per base pair coverage 
shows that SINE/Alus were depleted and LINE/L1 were enriched in transcript body 
of brain-specificncRNAs when compared with non-tissue-specific ncRNAs (Figure 
2F,  Supplementary  Table  2  worksheet  intersecting_repeats_bp_cov)  but  the 
difference was not statistically significant. 
Poor  representation  of  noncoding  Human  accelerated  regions  in  Brain-
specific ncRNAs 
Certain  regions  of  the  human  genome  are  termed  highly  accelerated  regions 
(HARs) because they are found conserved in human and primate species only 51-
54.  A  total  of  2,649  loci  in  humans  have  been  designated  noncoding  HARs 
(ncHARs)  and  they  were  recently  shown  to  function  as  enhancers  55.  We 
investigated if any of the brain-specific ncRNAs identified by us were arising from 
the ncHARs. Our data show minimal representation of ncHARs with only 5 brain-
specific ncRNAs harboring ncHARs (Table 1). In general we find HAR regions not 
highly represented in our dataset of brain-specific ncRNAs (Table 1). 
Discussion
We derived a set of ncRNAs expressed exclusively in the brain from the ncRNA 
dataset published in Nielsen et al [39] and investigated them for characteristics of 
nearby genes, associations with repeat  regions and representation of ncHARs. 
Nielsen et al presented a stratified assessment of tissue-specific ncRNAs divided 
by  genomic  location  (intergenic,  intronic  and  antisense)  and  analyzed  all 
transcripts for expression, conservation and overlap with epigenetic marks [39]. In 
our manuscript we extracted ncRNAs expressed only in the brain and compared 
them to ncRNAs expressed in more than one tissue and investigated them with 
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respect to genes in the vicinity, repeat elements at origin and in transcript body 
and  relationship  to  human  accelerated  regions. Our  data  show  that  brain 
expresses the highest number of tissue-specific ncRNAs. Surprisingly, among the 
1,744  non-tissue-specific  ncRNAs,  only  109, were  found  expressed  in  all  12 
tissues confirming earlier reports that ncRNAs are generally tissue-specific  15,  16. 
Analyses of GO terms of genes within 20 kb of brain-specific ncRNAs reveals that 
even though these ncRNAs are expressed exclusively in the brain, they are not 
located in the vicinity of protein coding genes with known brain-specific functions. 
Extending  our  window of  analyses  to  50  and  100  kb  did  not  yield  additional 
functionally relevant pc genes. Further, string network analyses revealed that the 
proteins encoded by neighboring genes were functionally unrelated to each other 
suggesting that brain-specific ncRNAs did not regulate expression of brain-specific 
biological or functional networks in cells. This finding may reflect the fact that we 
limited  our  analyses  to  genes  within  100  kb,  which  may  be  too  restrictive. 
Nevertheless, our data reveal that brain-specific ncRNAs are located within 20 kb 
of  genes  that  show  significant  enrichment  in  genes  up-regulated  in  brain 
suggesting a cis regulatory role for brain-specific ncRNAs. 
Even though the dataset used by us was filtered for repeat regions [39], we found 
that a significantly higher number of brain-specific ncRNAs originate near repeats 
in comparison with non-tissue-specific ncRNAs (p < 0.05). In both datasets (brain-
specific and non-tissue-specific ncRNAs) we find that a total of over 50% ncRNAs 
originate near LINE/L1 or SINE/Alu and less than 15% originate in LTR/ERVs. 
Our  data  are  in  partial  agreement  with  that  from  Kelley  et  al  who  showed 
significant enrichment of LTR/ERVs and depletion of LINE L1 and SINE/Alu at start 
sites of all lincRNAs  45 when compared with pc genes and genomic abundance. 
This discrepancy may result from the fact that there is poor co-relation between 
RNA-seq  and  microarray  data  for  low  expressed  lncRNAs  16,  there  were 
differences in data processing (repeats were filtered out of the microarray dataset 
and RNA-seq data  were  filtered to  retain  only  those multi-mapping reads that 
mapped to less than 50 places with high confidence), differences in data analyses 
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(we restricted our analyses to  100 bp upstream of start  sites and Kelley et  al 
looked for repeats up to 2000 nt upstream) and differences in datasets (Kelley et 
al  compared lincRNAs with  pc RNAs and showed enrichment /  depletion over 
genomic  abundance  while  we  compared  brain-specific  with  non-tissue-specific 
lncRNAs). Given the non random nature of distribution of SINE/Alus in the genome 
(Lander Nature 2001, Grover 2004 Bioinformatics, Medstrand Cytogenet Genome 
Research 2005) and the fact that SINE/Alu may offer binding sites to development 
transcription  factors  (Oei  2004  Genomics,  Polak  2006  BMC  Genomics),  this 
finding  recommends  further  investigation  into  the  expression  of  brain-specific 
ncRNAs during development. 
Investigation of  the  percentage of  ncRNAs harboring  repeats  shows that  even 
though  a  significantly  higher  number  of  brain-specific  ncRNAs  intersect  with 
repeats when compared with non-tissue-specific ncRNAs, brain-specific ncRNAs 
are significantly depleted in SINE /Alu and SINE / MIR and marginally enriched in 
LINE/L1 and LTR/ERVL.  The depletion  of  SINE/Alu  from brain-specific  ncRNA 
dataset may just reflect the tissue-specificity of this dataset since lncRNAs that 
contain SINE/Alu are expected to be less tissue-specific (Kelley). In view of the 
fact that TE containing lncRNAs are poorly expressed and that the presence of 
SINE/Alu confers greater expression (Kelley), our data indicate that brain-specific 
ncRNAs,  which  are  rich  in  repeats  and  depleted  in  SINE/Alu,  may  be  poorly 
expressed.  Analyses  by  base  pair  coverage  of  ncRNAs  by  repeat  families 
indicates that even though brain-specific ncRNAs are depleted in SINE/Alu and 
marginally enriched in LINE/L1, the difference was not statistically significant. 
We found minimal representation of ncHARs in tissue-specific ncRNAs, which may 
be due to the fact that ncHARs are generally less than 200 nucleotides in length 53, 
55 and  therefore  may  have  been  excluded  from the  custom  microarray  probe 
design due to length constraints. 
Our work presents the first analyses of brain-specific ncRNAs in the context of 
neighboring genes and repeat elements. It is tempting to speculate that the brain-
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specific  ncRNAs  play  a  role  in  up-regulating  the  expression  of  genes  in  their 
vicinity. Overall our data show that brain-specific ncRNAs are significantly likely to 
be poorly expressed and originate in repeat regions especially DNA/TcMar-Tigger. 
Further tissue-specific analyses of larger datasets and experimental validation will 
be important to decipher the role of brain-specific ncRNAs and the importance of 
repeats in the brain transcriptome.
Table1 : Summary of tissue-specific ncRNAs
Number of  tissue -specific  ncRNAs detected in  the custom microarray dataset 
(Nielsen et al). Percentages out of total are indicated in parenthesis 
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Tissue Number  of  tissue-
specific  ncRNAs 
(percentage  out  of 
total 3515 ncRNAs)
 Number  of  tissue-
specific  ncRNAS 
harboring  repeat 
elements  (percentage 
out  of  tissue-specific 
ncRNAs in that tissue) 
 Number  of  tissue-
specific  ncRNAs 
intersecting  with 
ncHARs 
(percentage  out  of 
tissue-specific 
ncRNAs  in  that 
tissue)
Bladder 95 (2.7) 49 (51.58) 1 (1.05)
Brain 303 (8.6) 202 (66.67) 5 (1.65)
Breast 104 (3.0) 64 (61.54) 2 (1.92)
Colon 132 (3.8) 79 (59.85) 2 (1.52)
Heart 150 (4.3) 92 (61.33) 5 (3.33)
Kidney 69 (2.0) 41 (59.42) 2 (2.90)
Liver 128 (3.6) 76 (59.38) 5 (3.91)
Lung 177 (5.0) 107 (60.45) 8 (4.52)
Muscle 83 (2.4) 55 (66.27) 2 (2.41)
Ovary 169 (4.8) 101 (59.76) 4 (2.37)
Prostate 247 (7.0) 144 (58.30) 4 (1.62)
Skin 112 (3.2) 64 (57.14) 1 (0.89)
 
Table 2: Repeat analyses of ncRNAS
Differences in repeat regions represented in brain-specific ncRNAs, other-tissue-
specific  ncRNAs and non-tissue-specific  ncRNAs with  respect  to  numbers  and 
location. See Supplementary Table 2 for a full list. Bold text indicates statistically 
significant difference.
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P Values of significance, Fishers test
Repeat comparison Brain-specific vs non–tissue-
specific
 Number of repeats at origin 0.002
LINE L1/at origin 0.56
SINE Alu at origin 0.21
SINE MIR at origin 0.18
LTR / ERVL at origin 0.68
Number of repeats in transcript body 0.0029
LINE L1 in transcript body by count 0.0007
SINE Alu in transcript body by count 4.2e-20
SINE MIR in transcript body by count 3.7e-08
LTR/ERVL in transcript body by count 0.003
Figure 1. Brain harbors the largest number of tissue-specific ncRNAs
a. Each  bar  represents  the  number  of  tissue-specific  ncRNAs  identified  in 
corresponding  tissues  as  labeled.  Brain  shows  the  highest  number  of  tissue-
specific ncRNAs (303, representing 17.1% of all tissue-specific ncRNAs), followed 
by prostate with 247. The counts for all tissues are shown in Table 1.  b. Panel 
showing DAVID "UP_TISSUE" category. The protein coding genes located within 
20kb  of  brain-specific  ncRNAs  are  enriched  for  genes  up-regulated  in  brain 
(Benjamini-Hochberg  adjusted  p-value  <  0.01).  The  length  of  each  bar 
corresponds to the number of genes present in each group.  c. STRING protein-
protein interaction network on the protein  coding genes located within  20kb of 
brain-specific ncRNAs: each circle (node) represents a protein-coding gene; nodes 
are connected when evidence exists that they interact at the protein level. The 
presence of very few connected nodes suggests that most of the protein-coding 
genes located within 20kb of brain-specific ncRNAs are not currently known to 
interact functionally.
Figure 1
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Figure 2. Repeat elements composition of expressed brain-specific and non-
tissue-specific ncRNAs.
a. Percentage of brain-specific and non-tissue-specific ncRNAs originating within 
100bp of repetitive elements. Overall a large percentage of ncRNAs originate from 
repeats  (57.3% to  66.7%),  with  the  largest  overlap  observed for  brain-specific 
ncRNAs. b. Distribution of repeats present at the origin of ncRNAs including major 
repeat families. The distribution is similar for the two groups, with LINE /L1 and 
LINE/L2  and  SINE/Alu  and  SINE/MIR  covering  almost  70%  of  all  the  repeat 
families  at  origin.  DNA/TcMar-Tigger  elements  are  over-represented  in  brain-
specific  ncRNAs.  c. Comparison  of  repeats  present  in  the  body  of  ncRNA 
transcripts.  The  percentage  of  brain-specific  and  non-tissue-specific  ncRNAs 
containing at least one repeat within the transcript is shown. The vast majority of 
the  ncRNAs overlap  at  least  one repeat  (85.1% to  91.4%),  with  brain-specific 
ncRNAs showing the largest overlap. d. Distribution of repeats present in the body 
of  ncRNAs.  The distribution  of  major  repeat  families  is  similar  across  the  two 
groups and the most represented families are LINE/L1 and LINE/L2 and SINE/Alu 
and SINE/MIR. LINE/L1 repeats are depleted from non-tissue-specific ncRNAs, 
which are enriched for SINE/Alu repeats. Brain-specific ncRNAs are significantly 
depleted of SINE/Alu and SINE/MIR repeats.  e. Percentage of ncRNA sequence 
derived from repeat elements for brain-specific and non-tissue-specific ncRNAs: 
for both groups about 50% of the sequence is repeat-derived.  f. Distribution of 
repeat-derived  sequence  across  the  major  repeat  families  investigated  in  this 
study. Although the pattern is similar to what obtained by counting the repeats in 
the gene body of the ncRNAs of the two groups (Figure 2d) the differences in  
terms of bp composition are not significant.
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Figure 2
110
Methods
From the published microarray dataset 39 we extracted all the ncRNAs expressed 
in a single tissue and in multiple tissues, as reported in the original publication. 
After evaluating the number of tissue-specific ncRNAs for each of the 12 tissues 
assessed in [39] we focused our analyses on the two sets of ncRNAs expressed 
exclusively in brain and in more than one tissue (referred to in the manuscript as 
“brain-specific” and “non-tissue-specific” respectively). To perform annotations “at 
origin” the 5' end of each tissue-specific ncRNA was extended upstream by 100 
nucleotides. All gene annotations were based on GENCODE v17. Annotation with 
respect to repeats was performed using RepeatMasker (downloaded from UCSC  
genome browser -  http://genome.ucsc.edu/ - on 2014/01/30) and significance of 
differences  between  groups  (ncRNAs  overlapping/non-overlapping  repeats  and 
proportion  of  distinct  repeat  families  at  origin  and  in  the  gene  body)  were 
evaluated using Fisher  exact  test.  The amount  of  repeat-derived sequence for 
brain-  and  non-tissue-specific  ncRNAs  was  derived  from  ncRNA annotations 
provided in [39] and intersection files. Significance of differences in the distribution 
of  bps covered by  distinct  repeat  families per  transcript  were  performed using 
Mann-Withney U test. Intersection with ncHARs was done considering a 5kb-long 
window.  All  intersections  were  performed  using  closestBed,  intersectBed  or 
windowBed from bedTools suite 56. Functional enrichment and gene up-regulation 
analyses were performed using DAVID  57,  58.  All  plots and statistical  tests were 
performed in R (http://www.r-project.org/).
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6.1 Results summary
The broad aims of this thesis were to gain insight into brain-specific and region-
specific transcriptional features and to create a high-resolution expression profiling 
atlas across distinct regions of the human aged CNS. To address these questions, 
we started out with a pilot project aiming at profiling TSSs in 5 regions of the CNS 
in human aged donors and investigate the relationships between methylation and 
expression.  The results  of  this study are presented in Chapter  2.  In summary, 
using CAGE as expression profiling technique, we found that a large proportion of 
the  genes  expressed  show evidence  of  alternative  promoter  usage,  which  we 
hypothesized to  be  a  major  mechanism in  establishing  transcriptional  diversity 
across distinct regions: 80% of the TSSs differentially expressed across regions 
were  alternative  transcription  initiation  sites  for  genes  that  also  expressed  a 
promoter  similarly  in  all  regions.  We  observed  limited  correlation  between 
methylation and expression levels; in particular differential methylation explained a 
limited proportion of the differential expression observed across regions (only 5% 
of the expressed TCs showed differences in expression that could be explained by 
methylation  effects).  Additionally  we  unexpectedly  found  that  75%  of  the 
methylation signal  was derived from gene bodies.  Surprisingly  the differentially 
expressed  TFs  showed  enrichment  in  functional  terms  related  to  neural 
development, despite the fact that the study was performed in aged donors and 
that neurons are terminally differentiated post-mitotic cells. In Chapter 3, as part of  
the  FANTOM5  consortium,  we  participated  in  the  creation  of  a  revolutionary 
CAGE-based promoterome atlas,  providing  expression  profiles  for  701 primary 
cells (573 from human and 128 from mouse) and 423 tissues (152 human post-
mortem and 271 mouse developmental samples), complemented with 250 human 
cancer cell lines. Notably, with this comprehensive dataset we were able to provide 
evidence of expression for 91% of the human protein-coding genes. Interestingly 
only a limited number of them (6%) could be considered truly housekeeping, in the 
sense that they were expressed ubiquitously (in more than 50% of the samples) 
and  uniformly  (less  than  10-fold  difference  between  median  and  maximum 
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expression). A crucial result of the study is that cell-specific expression is achieved 
by a combination of proximal TF motifs and highly specific enhancers and this 
mechanism  is  shared  by  both  CpG  Island  (CGI)  and  non-CGI  promoters; 
additionally many CGI promoters (54%) and most TATA promoters (98%) had non-
ubiquitous  expression  profiles.  In  Chapter  4  we  moved  the  focus  to  the  CNS 
samples  available  in  the  FANTOM  5  tissue  collection,  which  includes  frontal,  
temporal,  occipital  and parietal  cortices,  amygdala  and hippocampus,  caudate, 
putamen, thalamus,  globus pallidus,  locus coeruleus,  substantia  nigra,  medulla 
oblongata, spinal cord and cerebellum and represent an expansion of the data 
presented in Chapter 2. Using these data we were able to show that tissues of the 
CNS  have  a  distinctive  expression  signature  with  respect  to  all  other  tissues 
available in the collection and the defining elements of this specific signature are 
not only protein-coding genes and TFs, but also ncRNAs and intergenic peaks,  
that  represent  putative  new  transcripts.  Additionally  CNS  tissues  were 
characterized by higher transcriptional complexity, to which non-coding transcripts 
significantly  contributed.  We  showed  that  TSSs  up-regulated  in  brain  are 
characterized by a specific  transcriptional  context,  enriched in  simple and low-
complexity  repeats  and  CG-rich  regions.  When  investigating  region-specific 
expression signatures we identified 4 major co-expression groups that associated 
functionally  or  anatomically  related  regions:  e.g.  striatum  was  one  of  the 
expression  groups,  composed  of  caudate  and  putamen;  we  observed  similar 
expression signature across the cortex samples and amygdala and hippocampus, 
co-expression  group  that  we  denoted  as  “cortex-limbic  system”  group. 
Interestingly, analogous co-expression groups were also found when clustering the 
expression profiles of TFs and long non-coding RNAs (lncRNAs) up-regulated in 
the CNS tissues. Among transcripts with restricted expression patterns there were 
several ncRNAs and novel transcripts, which even though novel were supported 
by  good  evidence  that  they  are  genuine  transcripts.  Given  this  evidence  that 
ncRNAs are abundantly transcribed in the tissues of the CNS and contribute to 
regionally biased expression, we decided to further study the characteristics of 
brain-specific ncRNAs from another perspective. In Chapter 5, using a previously 
published custom microarray dataset, we investigated the landscape of ncRNAs 
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expressed  in  12  distinct  human tissues  and  showed that  brain  expresses  the 
largest  number  of  tissue-specific  ncRNA.  We  found  that  protein-coding  genes 
neighboring brain-specific ncRNAs are enriched for genes up-regulated in brain, 
however they didn't show enrichment in GO terms associated to brain function. We 
then investigated the representation of repetitive elements at the origin and in the 
gene  body  of  brain-specific  ncRNAs  and  found  that  significantly  more  brain-
specific ncRNAs originate and contain repeats with respect to non-tissue-specific 
ncRNAs. Investigation of the distribution across repeat families in the two groups 
showed that  DNA/TcMar-Tigger  elements  are  over-represented at  the  origin  of 
brain-specific  ncRNAs,  while  LINE/L1 repeats are enriched in  their  gene body, 
which is one the other hand depleted of SINE/Alu elements.
6.2 Discussion
With the work presented in this thesis we aimed at contributing to the knowledge 
about transcription in brain in general, and in distinct regions of it  in particular.  
When we started out in 2009, comprehensive expression studies of the human 
CNS were limitedly available,  typically performed on poorly characterized brain 
samples (e.g. age of the donor unknown) or limited to a very specific context, in 
terms of type of samples or regions of the CNS assessed (a single region relevant 
in  the  pathogenesis  of  a  specific  neurodegenerative  disease,  such  as  e.g. 
substantia nigra in PD). Dedicated brain studies existed, typically performed with 
microarray technology (e.g.  (Roth et  al.  2006))  and therefore burdened by the 
limitation of being able to profile transcription only for the genes spotted on the 
array. For these reasons we set out with the long term project of creating a high-
resolution expression atlas with the benefits of a novel technology and with well  
characterized samples, to be used in future work as controls for studies focusing 
on brain  of  patients  affected by neurodegenerative diseases.  In  parallel  to  our 
work,  in  the  last  few  years  very  interesting  studies  were  performed  to 
systematically profile transcription across distinct regions of the human CNS, at 
121
different  time-points  across  development,  maturation  and aging,  which  brought 
novel  information  and  important  resources  to  dissect  CNS  expression.  In 
particular, Colantuoni et al. provided a detailed study of human prefrontal cortex 
expression  dynamics  and  its  relationship  with  genomic  variation  in  a 
comprehensive series of post-mortem samples ranging in age from fetal to aged 
(Colantuoni et al. 2011). Kang et al. provided a detailed cross-region and cross-
age expression profiling study based on exon microarrays, complemented with 
information on genomic variation (Kang et al. 2011). Finally  Hawrylycz et al. and 
Miller et al.  presented extremely detailed atlases assessing expression in a very 
large array of anatomical regions of the CNS, for both adult (Hawrylycz et al. 2012) 
and developmental (Miller et al. 2014) samples. These works, although exhaustive 
in  terms  of  time-points  and  regions  assessed,  are  still  based  on  microarray 
platforms,  which  dramatically  limit  the  possibility  to  acquire  information  about 
currently  unknown  transcripts.  To  overcome  this  limitation,  we  designed  our 
expression profile studies based on a technique that is independent on currently 
known  annotations,  and  is  therefore  well  suited  for  the  discovery  of  novel 
transcripts.
With  our  work  we  show  that  the  CNS  is  characterized  by  specific  global 
transcriptional features. Importantly tissues of the CNS are characterized by higher 
transcriptional complexity with respect to other tissues. There is probably no doubt 
that brain is the most complex organ of the human body. In the past years there 
have been several studies suggesting that brain has a relatively high number and 
large variety of genes expressed (Ramsköld et al. 2009), that it is characterized by 
high rates of  alternative splicing (Yeo et  al.  2004) and that  brain-derived NGS 
libraries  have  high  transcriptional  complexity,  typically  surpassed  or  similar  in 
magnitude to testis (Jongeneel et al. 2005;  Ramsköld et al. 2009). Although we 
didn't find evidence that CNS expresses the largest number of genes (not shown), 
the  results  presented  in  Chapter  4  clearly  support  the  concept  that  the 
transcriptional complexity  of the CNS tissues exceeds that of the other tissues. 
One possible explanation for this is that  CNS tissues are composed of a very 
heterogeneous mixture of cell types. It is however difficult to test this hypothesis, 
even  in  the  largest  context  of  the  FANTOM5 promoterome atlas  presented  in 
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Chapter 3, because of the limited availability of distinct neuronal and glial primary 
cells in the collection. 
Brain tissues were also suggested in past studies to be characterized by a specific  
“transcriptional  context”,  i.e.  transcription  for  brain-specific  genes  initiates  in 
genomic  regions  characterized  by  enrichment  in  CG rich  regions  and  specific 
repeat elements (Faulkner et al. 2009; Roider et al. 2009; Xu et al. 2010). In line 
with these observations, in Chapter 4 we show that TSSs up-regulated in the CNS 
often originate in CG-rich regions as well as in simple and low complexity repeats. 
That  a  relationship between brain-specific  transcription and repeats distribution 
exists, is further supported by the study presented in Chapter 5, where we show 
that brain-specific ncRNAs generally originate and contain repeats more frequently 
than non-tissue-specific  ncRNAs and that  specific  repeats classes seem to  be 
involved. This is particularly interesting in light of the fact that expressed repeats 
have been shown to be non-randomly distributed across the genome (Xu et al. 
2010;  Kelley and Rinn 2012) and are suggested to be actively involved in the 
regulation of gene expression, by providing alternative promoters (Cohen et al.  
2009),  alternative  exons (Shen et  al.  2011)  or  by  being  associated  to  specific 
transcript classes and tissue-specific expression patterns (Kelley and Rinn 2012).
The results presented in Chapters 3 and 4 clearly show that the CNS system has 
an overall  transcriptional  profile  that  neatly  separates  it  from other  tissues,  as 
suggested  in  the  first  large  expression  profiling  work  performed  on  a 
comprehensive selection of different regions of the human post-mortem CNS and 
other tissues (Roth et al. 2006). Interestingly this is true not only at the level of 
protein-coding  genes,  which  would  be  somehow  expected  since  very  specific 
components  are  needed  and  produced  in  the  CNS  (e.g.  all  the  molecular 
components that participate in the synthesis and secretion of neurotransmitters). 
Strikingly, instead, the CNS samples are set apart from all  other tissues in the 
human  body  considering  also  expression  from less  well  established  transcript 
classes,  such  e.g.  lncRNAs  and  CAGE-defined  intergenic  peaks,  most  likely 
indicating  novel  transcripts  or  TSSs.  Among  the  protein-coding  genes,  TFs  in 
particular  are  clearly  determining  CNS  signature,  in  line  with  the  observation 
presented in Chapter 3 that related primary cells clearly cluster together based on 
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TF expression. Unexpectedly, part of the TFs up-regulated in the CNS identified in 
Chapter 4 are not pointed out by literature as key elements for the CNS function,  
while the remaining are well known for their crucial role in brain development. In 
terms of TFs, in Chapter 2 we find enrichment of neurodevelopmental functional 
terms in the  set  of  TFs  differentially  expressed  across  regions:  this  might  be 
surprising at first sight, but it is reasonable that TFs that are important for neural  
development keep playing a role in the aged brain, although it would be interesting 
to investigate their exact functional role there. 
In Chapter 2 we also discovered that abundant methylation signal in the distinct 
brain regions profiled is located in gene bodies and that there is limited correlation 
between methylation and expression.  In  retrospective,  several  reports  are now 
available showing how the relationship  between methylation  and expression is 
more intricate than originally established (reviewed in (Jones 2012)). In particular it 
is suggested that methylation in the gene bodies is a widespread phenomenon 
linked  to  the  regulation  of  alternative  promoter  usage  and  alternative  exon 
inclusion (Maunakea et al. 2010; Maunakea et al. 2013).
Moving  towards  a  more  global  picture  of  transcription,  we  participated  in  the 
creation of the comprehensive promoterome atlas presented in Chapter 3. This 
work provides the scientific  community with a powerful  resource, thanks to the 
creation of several easily accessible integrative analyses. User-friendly tools allow 
for the easy access to relevant TFs and putative regulators in specific cell types 
and tissues, which can be readily used to formulate hypothesis to be tested at the 
bench.  Additionally  a  guilt-by-association  approach  provides  putative  functional 
annotation  to  transcripts  for  which  current  information  is  limited.  An  important 
observation that  emerges from the study is that  only a very limited number of 
genes can be considered as truly housekeeping, which raises important reflections 
in  the  view  that  housekeeping  genes  are  often  used  to  perform  internal 
normalizations. It is also important to note that cancer cell lines expression profiles 
tend to  be divergent  from their  tissues of  origin,  while  primary cell  expression 
profiles cluster together with their tissue counterpart. This suggests that primary 
cells should be the system of choice when studying phenotypes that are relevant 
for  a  specific  tissue.  Given  the  improvement  in  induced  pluripotent  stem  cell 
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(iPSC) technology and the advent of standardized characterization guidelines for 
differentiated cells, a viable alternative that is starting to emerge is given also by 
differentiated iPSC.
The second aim of this thesis was to  create a high resolution expression profile 
atlas of distinct brain regions from aged donors. This aim was first approached in 
Chapter  2  and was then expanded in  Chapter  4,  with  the  creation  of  a  high-
resolution  expression  atlas  for  15  regions  of  the  human  CNS.  We  identified 
extensive  differences  in  expression  across  regions: unexpectedly  we  didn't 
observe expression signatures specific for each of the regions profiled but rather 
transcription profiles that tend to be similar between developmentally, functionally 
or morphologically related regions, with cerebellum showing the most distinctive 
expression  signature  and  the  largest  number  of  differentially  expressed  TCs, 
consistently with results presented in (Kang et al. 2011; Hawrylycz et al. 2012). 
One  of  the  most  innovative  contributions  of  the  works  presented  here  is  the 
identification of large sets of brain-specific and region-specific ncRNAs and novel 
transcripts expressed. In the last few years awareness that several ncRNAs are 
key actors in the largest variety of biological processes started to emerge, such as 
regulation of gene expression through chromatin modifications (Khalil et al. 2009; 
Saxena and Carninci 2011) and enhancer activity through transcribed RNAs (Kim 
et al.  2010) and lncRNAs (Ørom et al.  2010).  Additionally it  has been recently 
shown  in  mouse  that  long  intergenic  ncRNAs  are  required  for  life  and  brain 
development (Sauvageau et al. 2013). From the studies presented in Chapters 2, 
4 and 5 it  becomes apparent that brain hosts expression for a  large variety of 
ncRNAs and that these have expression patterns comparable to that of protein-
coding genes. Additionally the study presented in Chapter 5 suggests that they 
have specific characteristics in terms of repeat expression. Certain types of repeat 
elements were proposed to have specific active roles in the regulation of gene 
expression (Cohen et al. 2009; Xu et al. 2010; Shen et al. 2011; Kelley and Rinn 
2012). A particularly intriguing example of transcriptional regulation mediated by a 
repeat  element  is  given  by  (Carrieri  et  al.  2012).  This  study  shows  that  the  
expression of the gene Uchl1, which human homologue is a susceptibility gene for 
PD (Maraganore et al. 2004), is regulated post-transcriptionally by an antisense 
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non-coding transcript  and that  the regulation  is  mediated by an inverted SINE 
repeat embedded in the ncRNA. This suggests an intriguing mechanism by which 
ncRNAs might  be involved in high-level  regulation of expression that  might  be 
relevant for neurodegeneration.
6.3 Limitations
There are several aspects in the works presented in this thesis that should be 
considered  with  critical  eye.  To  start  with,  we  mainly  focused  on  expression 
profiling based on CAGE technique. Although unmatched to precisely identify the 
genomic location of  TSSs and therefore ideal  to  characterize alternative TSSs 
differentially used in distinct tissues or brain regions, it is affected by the inherent  
limitation of being completely focused on transcription initiation events and not 
allowing for the investigation of the full length nature of the transcripts identified, 
such as e.g. intron-exon alternative structures. RNA-seq (Mortazavi et al. 2008) is  
an  alternative  genome-wide  expression  profiling  technique  widely  used  in  the 
production phase of the ENCODE project.  This technique doesn't  allow for the 
same precision in the identification of TSSs, but provides information about the full  
length structure of the transcripts, although building transcripts  de novo is still a 
challenging problem, specially for samples with complex splicing patterns and high 
sequencing  depth  (Steijger  et  al.  2013).  It  has  been  recently  shown  that 
expression levels assessed by CAGE and RNA-seq are largely comparable, and 
therefore the two techniques can be efficiently used in combination to improve 
information  about  new  or  incomplete  gene  models  (Kawaji  et  al.  2014). 
Considering the technology itself, it is important to notice that CAGE is not suitable 
for the profiling of short RNAs without a specific adaptation of the protocol, since 
typical  cDNA preparation protocols  exclude RNAs shorter  than 500bp (Wu ed. 
2013).
It  is  important  to  highlight  that  these  RNA-based  studies  provide  indeed 
information at the RNA level, but this doesn't always directly correlate with protein 
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expression levels (Gry et al. 2009). Although recent technological advances, the 
large-scale identification of proteins in a sample is still a challenging problem and 
typically provides information for a limited number of peptides. A viable alternative 
is ribosome profiling (Ingloia et al. 2009), which uses RNA sequencing technology 
to monitor  protein synthesis.  Although this  is  clearly  an important step forward 
towards  genome-wide  protein  profiling,  the  technique  cannot  incorporate 
information  about  protein  stability  and  degradation  rates,  and  therefore  still  
provides an incomplete picture.
Another point to be considered is the use in the studies presented here of post-
mortem material. It's been suggested that expression profiles derived from post-
mortem material can be affected by biases related to e.g. the agonal state (Li et al.  
2004). In our studies, besides the observation that libraries prepared with material 
with low RNA integrity  number (RIN) typically fail  at  the sequencing stage, we 
didn't observe systematic biases in expression directly correlated to post-mortem 
delay, RIN number or pH, all measures that can be altered due to agonal state. It 
is still possible, however, that biases in the data exist that we didn't account for yet. 
It is certainly true, for example, that the relative degradation rates across distinct 
RNAs  influence  RNA  expression  profile  measures;  however  it  was  recently 
suggested that only heavy degradation has effects that can be measured by RNA-
seq (Gallego Romero et al. 2014). It would be interesting to compare post-mortem 
brain material with surgically removed tissue: however on the one hand surgically 
removed tissue is difficult to access and is usually available in limited amounts that 
represent a technical challenge for an expression profiling study, on the other hand 
a tissue derived with such a procedure would still be subject itself to a specific  
stress, so it could in principle be affected by other but not less important biases.  
From this point of view, it is likely that an efficient workaround doesn't exists, and 
the only sensible approach is to  carefully  evaluate the presence of  systematic 
biases in the data, and remove the samples from the analyses if such biases are 
identified and cannot be corrected at the analysis level. 
In Chapter 4, although a large number of CNS regions were profiled, we were 
unable to identify expression signatures for each of them. This is partly consistent 
with other publications, reporting that the largest differences between CNS regions 
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are observed during prenatal development (Kang et al. 2012). There are however 
two additional possible explanations for this, besides the one suggesting that there 
is indeed no difference. It is possible that differences in expression are very small,  
and therefore we would need to expand the sample size in order to have a higher 
resolution. Alternatively, it is possible that all the differences between e.g. frontal 
and temporal cortex are limited to subsets of cells in the tissues profiled, and since 
we are measuring only averaged expression we are unable to detect them. This 
last  possibility  could  be  explored  by  undertaking  laser  capture  or  cell  sorting 
approached.
6.4 Future directions
Importantly, the third aim of this thesis was the complementation of the region-
specific  expression  atlas  with  data  derived  from  patients  affected  by 
neurodegenerative diseases.  We are currently  in the process of  collecting and 
analyzing expression data derived from different CNS regions of patients affected 
by familial FTD with underlying mutations in distinct genes. The plan is to analyze 
expression  in  a  network  framework,  in  order  to  identify  pathways  that  are 
commonly and differently dysregulated across both distinct mutations and distinct 
regions.  Besides  dealing  with  already  established  pathways  and  interacting 
elements, taking advantage of correlation structures present in the data and using 
network  analysis  approaches  (such  as  weighted  gene  co-expression  network 
analysis – WGCNA (Fuller et al. 2007)) it is possible to identify novel interactors. 
On the one hand we aim at understanding the biological processes that through 
distinct  mutations  give  rise  to  what  can  be  broadly  considered  as  the  same 
phenotype (FTD). On the other hand by including in the study regions of the CNS 
that are affected at different grades of severity by the disease gives an important  
opportunity to gain insight into region-specific vulnerability to neurodegeneration. 
While  expression  profiling  and  network  analysis  identify  potential  pathway 
elements, appropriate systems are needed for validation and causal-relationship 
assignment. A powerful approach to investigate this is given by high-throughput 
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high-content  cellular  screens,  that  can  be  used  to  impose  direct  regulatory 
interactions in the elements of the pathway (Jain and Heutink 2010). In particular, 
experiments can be performed in iPSCs derived from patients and controls, which 
gives  a  readout  in  a  cell-type  specific  system that  is  particularly  close  to  the 
disease.
As  a  more  global  outlook,  all  the  work presented  in  this  thesis  focused  on 
transcription profiling. However this is only one aspect of the global picture and it is  
becoming clear that more comprehensive studies are needed to explain complex 
biological phenomena, such as transcription. Current lines of research are starting 
to  migrate  from  transcriptome  alone  to  other  “-omes”,  such  as  interactome, 
epigenome, etc. It is undoubtedly true that these novel layers of regulation that we 
are starting to  dissect  and understand play an important  role  in  the CNS. For 
example, recent studies suggest that aberrant histone acetylation is the cause of 
abnormal transcriptional profiles observed in aging brain (Pirooznia and Elefant 
2013).  I  find  particularly  intriguing  the  technique  of  chromosome conformation 
capture,  which  allows  for  the  identification  of  the  portions  of  the  genome that 
physically interact in the three-dimensional space of the nucleus. Comprehensive 
studies in subsets of cell lines from the ENCODE project suggest that an important  
part  of  transcriptional  regulation  happens  at  the  “neighborhood  level”:  e.g. 
enhancer  sequences are  physically  close to  their  target  genes,  and when the 
physical interaction is disrupted, the enhancer activity is disrupted as well. 
I also believe that an important challenge for future research is “integration”, not 
only at the level of datasets but also at the level of knowledge, using systems 
biology  approaches  that  allow  for  the  integration  of  datasets  and  information. 
Additionally, there is an incredible need to improve functional annotation. In the 
studies presented here we identified thousands of transcripts that are expressed 
specifically in brain or in specific super-groups of regions of the CNS; however, the 
information available about their function is very limited and often absent, which 
makes very complicated the formulation of hypothesis based on the data.
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6.5 Conclusions
The aims of this thesis were:
1. to gain general insight into the dynamics of transcription in the CNS
2. to  specifically  create  a  high  resolution  expression  profile  atlas 
encompassing distinct regions of the CNS in aged donors
3. to extend the atlas to matched disease samples, in order to identify and 
functionally  validate  networks  of  co-expressed  transcripts  perturbed  in 
disease
In Chapters 3, 4 and 5 we investigated transcriptional features and expression 
profiles of the CNS with respect to other tissues of the human body. We identified 
transcriptional contexts, transcriptional characteristics, TFs and ncRNAs that are 
CNS-specific, fulfilling the first aim of this thesis. In Chapter 2 we created a high-
resolution  expression  atlas  encompassing 5  regions of  the  aged human CNS, 
which we expanded in Chapter 4 by adding 10 additional anatomical regions. We 
identified  several  coding  and  non-coding  transcripts  that  are  expressed  in  a 
regionally biased manner, fulfilling the second aim of this thesis. The third aim is  
currently ongoing, and it is discussed as a future direction. Overall, with the work 
presented here, we provide high-resolution expression information about coding 
and non-coding genes expressed in the CNS and its distinct regions. We supply 
powerful resources for hypothesis making and testing and for gaining insight into 
mechanisms involved in the regulation of gene expression in brain. Additional work 
and data production is  under  way and will  importantly  complement the  results 
already achieved. In particular the growing amount of high quality expression data 
available,  along  with  new  analysis  and  validation  techniques,  is  importantly 
contributing to the dissection of CNS expression features and will  improve our 
understanding of regional vulnerability in neurodegenerative diseases. Thanks to 
system biology perspectives and approaches ,the next years will see the advent of 
new understanding in the pathogenesis of these diseases, opening the door to 
new therapeutic and preventive strategies.
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